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Executive Summary 
    
Central venous access devices (CVADs) are associated with serious 
complications, including central line associated bloodstream infection (CLABSI), that 
place patients at risk for poor outcomes and are costly for hospital systems.  Research 
suggests great variability of CVAD use in hospitals including overuse and inappropriate 
use of these devices which places patients at unnecessary risk for complications.  Each 
unique patient situation involves multiple characteristics that adds complexity to their 
hospitalization. Clinicians make decisions regarding line selection often during emergent 
situations without the appropriate level of evidence to support this decision, which results 
in inconsistencies and variations in the use of CVADs. Vascular access nurses, 
specialized clinicians who place and maintain vascular access devices (VADs) in 
hospitalized patients, are often involved in decision making regarding VAD use.  
Providing these specialized clinicians with the latest evidence-based decision support 
tools and the knowledge needed to interpret this information to determine the most 
appropriate VAD for an individual patient may impact VAD utilization. Empowering 
vascular access nurses to appropriately evaluate and decide if a patient meets the criteria 
for CVAD insertion prior to placement could prevent unnecessary exposure to potentially 
dangerous and costly complications.  The proposed project objectives include introducing 
an evidence-based guideline for use by the vascular access team to support VAD 
selection for hospitalized adult patients at a large academic medical center.  Decision 
support guidelines are composed of evidence-based recommendations from Michigan 
Appropriateness Guide for Intravenous Catheters (MAGIC) resources.  The algorithms to 
be implemented address various complex patient scenarios that challenge clinicians when 
 
 
choosing the most appropriate VAD.  Project goals include improving appropriateness of 
VAD selection through recommendations from vascular access nurses using MAGIC 
resources as evidence-based guidelines in clinical decision making.  Achieving these 
goals may result in a decrease in inpatient CVAD use and a reduction in serious 
complications associated with CVADs.  Objectives are aimed at improving the quality of 
patient care by using the latest evidence for vascular access recommendations.  Improved 
quality of care can reduce health care costs by preventing serious and life-threatening 
complications that prolong the hospital length of stay and require additional unnecessary 
therapies and hospital readmissions.  
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Appropriateness of Vascular Access Device Selection 
 
Background/Statement of the Problem 
  
 Vascular access device (VAD) placement is the most common procedure 
performed in hospitalized patients (Chopra, Kuhn, Ratz, Flanders, & Krein, 2016). VADs 
are catheters inserted into the peripheral or central vessels for the purposes of monitoring, 
diagnostic procedures, or therapeutic administration of medications and fluids.  Central 
venous access devices (CVADs) are placed in hospitalized patients for a variety of 
reasons including administration of vesicants such as chemotherapy or parental nutrition, 
administration of long-term antibiotics, hemodynamic monitoring for critically ill 
patients, frequent blood sampling, and establishing a secure access for patients with poor 
or inaccessible venous access.  CVADs are associated with serious complications, 
including central line associated bloodstream infection (CLABSI) and deep vein 
thrombosis (DVT), that place patients at risk for poor outcomes and are costly for 
patients and hospitals. Less serious complications associated with these lines include 
vascular occlusions, dislodgements, and insertion site infection (Chopra et al., 2015).  
 One type of CVAD, the peripherally inserted central catheter (PICC) has 
increased in popularity in recent years due to benefits including cost-effectiveness and 
convenience of use as patients can be discharged home with these devices to complete 
treatment regimens (Chopra et al., 2015).  PICCs also offer decreased risk during 
placement, when compared to other CVADs, with use of insertion techniques that can be 
safely performed by vascular access nurse teams at the patient’s bedside. PICCs, like 
other CVADs, are associated with both serious and less serious complications.  Research 
suggests variability of PICC use in hospitals including overuse and inappropriate use of 
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these lines that places patients at unnecessary risk for complications. Appropriate 
indications for PICC placement in the literature establish criteria for PICC line insertion 
that is critical to preventing unnecessary exposure to potentially dangerous and costly 
complications (Chopra et al., 2015).    
  A midline catheter (MC), a type of VAD that is not considered a central catheter, 
is inserted peripherally into the arm and extends 8-20 cm in length to or below the 
axillary vein (Adams, Little, Vinsant, & Khandelwal, 2016).  MCs are associated with 
significantly lower rates of the serious complications, including CLABSI and DVT, than 
PICCs.  MCs offer a longer duration of use, up to 28 days, than standard peripheral 
intravenous catheters (PIV), providing the benefit of less frequent venipuncture for 
patients. MCs offer a potential for decreased complications associated with central lines 
and a cost-effective alternative for long-term intravenous (IV) therapy (Adams et al., 
2016).  The current guidelines recommend that infusions through MCs have a pH 
between 5 and 9 and osmolarity of < 600 mOsm, however some clinicians remain 
concerned about the administration of vesicants through MCs as this was previously 
contraindicated in the literature.  Research now demonstrates safe administration of these 
medications through a MC and recommends these medications no longer be an indication 
for central line access (Adams et al., 2016).  
 The AccuCath Intravenous Catheter System, a type of ultrasound guided 
peripheral IV (USGPIV) is a recent addition to VAD options.  USGPIVs offers a longer 
dwell time than conventional PIVs but are shorter in length than MCs. These USGPIVs 
are placed with a retractable coiled tip guidewire to increase first attempt insertion 
success rates. Current research demonstrates an increased rate of first attempt placement 
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success, reduced complication rates, reduced costs, and increased patient satisfaction 
associated with extended dwell time when compared to conventional PIVs (Idemoto, 
Rowbottom, Reynolds, & Hikman, 2014). 
 PICCs, traditionally placed by interventional radiologists, are now primarily 
placed by dedicated vascular access nurse teams in hospitals (Chopra et al., 2016).  The 
growth of the vascular access nurse specialty has contributed to the rapid growth of PICC 
use, as these specialized teams offer benefits of high insertion success rates and decreased 
costs associated with placement.  Vascular access nurses are involved in the placement of 
many VADs in hospitals, having vascular access nurse practice routed in the principles of 
an evidence-based criteria for decision making provides an opportunity for improved 
device selection and interprofessional collaboration.  
 Choosing the most appropriate line for a patient can be difficult as each patient 
situation includes multiple characteristics that create a complex scenario during 
hospitalization.  Clinicians make decisions about VAD selection frequently under urgent 
circumstances and often without the necessary level of evidence to support the decision-
making process.  This lack of decision support results in inconsistencies between practice 
and inappropriate use of CVADs in hospitalized adults (Chopra et al., 2015).   The 
MAGIC decision criteria, developed by an international panel of experts, establishes a 
guideline for indications and appropriate use of VADs by clinicians.  This guideline 
supports the clinician to determine the most appropriate VAD for an individual patient to 
minimize risk associated with unnecessary CVAD use, particularly PICCs.  Providing 
clinicians with necessary VAD decision support is essential to decreasing unnecessary 
risk for patients and associated costs. 
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Purpose Statement 
 
 The purpose of this project is to equip vascular access nurses with the Michigan 
Appropriateness Guide for Intravenous Catheters (MAGIC) evidence-based guidelines 
and knowledge necessary to support clinical decision making in VAD selection.   
Literature Review 
 
 A comprehensive review of relevant literature from 2008 to 2019 was performed 
using CINAHL (Cumulative Index to Nursing and Allied Health Literature), Ovid, and 
PubMed databases. Keywords searched included venous access device, central venous 
access device, central venous catheter, peripherally inserted central catheter, midline 
catheter, ultrasound-guided peripheral intravenous catheter, peripheral intravascular 
catheter, peripheral intravenous line, vascular access nursing, and clinical decision 
support. Articles not available in English and not including hospitalized adult populations 
were excluded. 
Patient Safety and Quality  
According to the Centers for Disease Control and Prevention (CDC) (2011a) 
healthcare-associated infections (HAIs) are infections that patients can contract while 
receiving medical care that negatively impact patient outcomes and increase healthcare 
costs.  HAIs caused by bacterial, viral, and fungal pathogens, can develop during any 
stage of patient care and across all health care settings.  HAIs include central line-
associated blood stream infections (CLABSIs), catheter-associated urinary tract 
infections, surgical site infections, and ventilator-associated events.  CLABSIs are 
infections occurring when pathogens enter the bloodstream via CVADs (CDC, 2011a). 
CVADs are intravenous catheters placed in large vessels of the chest, groin, or neck for a 
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variety of treatments or hemodynamic monitoring.  CLABSIs are preventable, but still 
occur across health care settings and result in unnecessary death and billions of dollars in 
additional health care costs each year (CDC, 2011a).  
Defined by the CDC (2019), a primary bloodstream infection is an infection of the 
bloodstream confirmed by laboratory that is not secondary to another infection in the 
body at a different site.  A central line, or CVAD, is defined by the CDC (2019) as an 
intravascular catheter terminating in a vessel close to the heart or another great vessel that 
is used for infusions, hemodynamic monitoring, or blood sample.  A CLABSI is defined 
as a bloodstream infection with an eligible bloodstream infection organism identified and 
confirmed by laboratory test, when an eligible device is present on the day of or day 
before infection is detected (CDC, 2019).  Eligible bloodstream infection organisms are 
all organisms not excluded for use in meeting criteria for laboratory confirmed 
bloodstream infection.  Eligible CVADs are defined as a CVAD that has been accessed 
for use and is present for more than two consecutive days in an inpatient location during 
the current admission (CDC, 2019).  These eligible CVADs are eligible for CLABSI 
events until patient discharge or removal from patient’s body.   
Significant progress in HAI prevention has been made recently, specifically 
hospitals across the U.S. have seen a 46% decrease in CLABSIs from 2008-2013 (CDC, 
2018).  It is estimated that over 30,000 CLABSIs still occur each year. Health care 
providers must adhere to strict evidence-based procedures during placement and 
maintenance care of CVADs to reduce the risk of CLABSI occurrence (CDC, 2018). 
According to the CDC (2011b), CLABSIs are preventable through adherence to strict 
insertion and care techniques described in CDC guidelines. This document, prepared by 
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the CDC, serves to guide health care professionals through evidence-based practice 
recommendations to prevent CLABSI.  Recommendation highlights include emphasis on 
appropriate training and education of providers, sterile technique during insertion, use of 
antiseptic/antibiotic impregnated dressings, and use of CLABSI prevention bundle 
techniques (CDC, 2011b).  
PICCs 
Secure vascular access is essential to care of most hospitalized patients.  
Advances in medical equipment technology have produced several VADs that offer 
improved benefits for patients, including the ability to receive necessary intravenous 
therapy outside of hospital. The peripherally inserted central catheter (PICC), developed 
in the 1970s, is inserted peripherally then threaded to centralized veins and therefore are 
categorized as a CVAD (Chopra, Flanders, & Saint, 2012). PICCs have gained popularity 
as a potentially safer alternative to centrally inserted central catheters (CICCs) for 
hospitalized patients as they have demonstrated reassuring data for decreased CLABSI 
incidence when providers worked actively to remove unnecessary PICCs in practice (Al 
Raiy et al., 2010; Gunst et al., 2011).   
PICCs have demonstrated appealing advantages over CICCs for patients and 
providers alike.  Specialized vascular access nurses are trained to safely insert PICCs at 
the bedside to decrease the cost of previously required interventional radiology 
procedures (Meyer, 2012).  Patient satisfaction and comfort are positively impacted as the 
PICC can be placed in a timely fashion and does not require the patient to leave their 
room (Meyer, 2012).  PICCs offer additional patient satisfaction opportunities as they 
allow for blood draw for routine labs, avoiding painful and frequent phlebotomy draws 
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(Chopra et al., 2012).  Due to peripheral insertion techniques used, PICCs are safer to 
insert than other CICCs and can remain safely in place for long periods of time and avoid 
routine peripheral access replacement (Chopra et al., 2012).  PICCs decrease costs by 
significantly decreasing hospital length of stay as patients can be discharged with a PICC 
in place and continue intravenous therapy after discharge (Chopra et al., 2012).  These 
advantages have made PICCs the most common CVAD used for patients outside of 
intensive care units (ICUs) (Chopra et al., 2012). 
As use of PICCs has grown worldwide, concerns of associated complications, 
including CLABSI, and inconsistent use have appeared in the literature (Chopra et al., 
2015).  As PICC use grew, research related to PICC use and associated complications 
was limited to single-site studies among ideal populations.  This limited research 
supported continued PICC use and lacked an accurate comparison of complication rates 
compared to other CVADs.  Evidence-based guidelines regarding appropriate indications 
for PICC use given various clinical scenarios were not available in the literature (Chopra 
et al., 2015).  Without research and evidence-based guidelines supporting best practice, 
variability and inappropriate PICC use flourished.  
Increase popularity in PICC use may be related to perceptions that PICCs are a 
safe alternative to other CVADs (Chopra et al., 2012).  Early studies suggesting PICCs 
may be associated with lower rates CLABSI when compared to other CVADs supported 
provider preferences to these devices.  As more research was conducted, evidence 
suggesting PICC-related complications may be multifactorial emerged (Chopra et al., 
2012).  Research exploring patterns of use and practice variation in use of PICCs is 
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limited. Given this gap in evidence, providers have limited resources to support best 
practice related to PICC use. 
Use of PICCs 
PICC placement in hospitalized patients often requires an order from a provider 
and are placed for a variety of indications.  Understanding the practice of hospital-based 
providers, who make up a large portion of providers of inpatient care related to decisions 
for PICC insertion can provide useful information to understand current PICC use in 
hospitals.  Chopra et al. (2013) conducted a web-based survey of a convenience sample 
of 227 hospitalists from five large healthcare systems in Michigan to explore provider 
practices related to PICC use. The survey was developed from an evidence-based 
framework of PICC-related complications categorized into the domains of hospitalist 
experience, knowledge, opinions, and practice regarding PICC use. The survey was pilot 
tested with a group of randomly selected hospitalists.  A survey response rate of 63% was 
obtained with 144 respondents completing the survey for the study (Chopra et al., 2013).  
Hospitalists reported long-term IV antibiotic treatment as the most common 
indication for PICC placement, followed by difficult venous access (Chopra et al., 2013).  
Hospitalists reported caring for patients who had PICCs and PIVs in place at the same 
time and 87% of participants reported inserting a PICC because a patient specifically 
requested a PICC for difficult venous access.  Only 35% of participants reported selecting 
the lowest number of lumens possible when ordering a PICC.  Sixty-nine percent of 
hospitalists felt that PICCs were safer and more efficient than CICCs because they could 
stay in place longer and thought they were associated with a lower risk of infection.  
Seventy-four percent of participants reported patients preferred PICCs to avoid pain with 
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scheduled PIV changes and phlebotomy, and 65% stated PICCs were more convenient 
because they could be placed by vascular access nursing teams. Hospitalists reported that 
PICCs may be placed inappropriately in their hospitals and 84% agreed that it was 
appropriate to place a PICC if other forms of peripheral access could not be obtained. 
Seventy-eight percent of hospitalists stated that the increase in vascular access nurse 
teams had increased the use of PICCs in hospitalized patients (Chopra et al., 2013). 
The survey results demonstrated significant variation in reported practice, 
opinion, and knowledge related to PICC use among hospitalists (Chopra et al., 2013).  
Despite the evidence associating PICCs with serious complications, PICC use in hospitals 
is not decreasing.  Hospitalists reported keeping PICCs in place that are no longer 
indicated. Hospitalists who reported providing direct patient care and practicing for less 
than five years were more likely to be aware of the inappropriate use of PICCs and 
acknowledge the influence of vascular access nurse teams on PICC placement rates 
(Chopra et al., 2013).  Understanding the practice of hospitalists in relation to PICC use is 
essential to impacting VAD selection as these providers are often responsible for PICC 
selection and orders for placement and removal. Survey results demonstrated several gaps 
between evidence-based PICC indications and current practice by hospitalists (Chopra et 
al., 2013).  Clinical knowledge and integration of evidence-based criteria to guide 
vascular access device selection is needed to standardize clinical decision making and 
prevent unnecessary device use and associated complications. 
Midline Catheters 
Pathak et al. (2015) conducted a retrospective cohort study to evaluate the effect 
of MC use in place of CVADs on CLABSI rates on a ventilator dependent unit where 
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patients required long-term care outside of a nursing home.  The researchers used two 
separate study periods, including one year of catheter days before MCs were 
implemented (Group A) and one year of catheter days after MCs were introduced (Group 
B). The population studied had the highest catheter days per unit, likely related to the 
unit’s greater than average length of stay and reported frequent venous access difficulties. 
CVADs were placed on this unit for long-term use, challenging venous access, blood 
draws, antibiotic administration, blood transfusions, and diagnostic procedures (Pathak et 
al., 2015).  
Researchers collected data pertaining to catheter days, CLABSI rate per 1000 
catheter days, type of bacteria associated with CLABSI, and date of culture from the 
infection control department (Pathak et al., 2015).  During the time period between the 
two collection groups, nurses and medicine residents were trained to insert MCs to 
replace CVADs whenever indicated as a new practice intervention.  Practice changes 
with MC introduction included replacing any femoral CVAD with a MC, replacing all 
CVADs with MCs for patients not on total parenteral nutrition (TPN) or an inotropic 
agent, replacing CVADs in place longer than one week with MCs, placing MCs for 
patients being discharged to nursing home with IV antibiotics, and discontinuing MCs at 
dwell duration limit of 28 days or once access was no longer needed.  Catheter days, 
calculated as the number of CVADs on the unit every day, and CLABSI rate were 
compared between the two groups and reported as CLABSI rate per 1000 catheter days 
(Pathak et al., 2015). 
 Catheter days decreased significantly after the MC program was introduced with 
2408 catheter days and 3058 inpatient days in Group A and 1521 catheter days with 2948 
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inpatient days for the Group B study period. A statistically significant decrease in 
CLABSI rate was observed with a rate of 3.32 per 1000 (Group A) to 0 per 1000 catheter 
days (Group B). Two patients developed phlebitis with MCs, no blood stream infections 
were found to be associated with MCs, and one patient developed a pneumothorax that 
was associated with CVAD insertion (Pathak et al., 2015).  
 The researchers note the significance of an average catheter dwell time of greater 
than 9 days as a factor to CLABSI development as described by the CDC 
recommendations.  Authors contribute reduction of CLASBI rates to elimination of risks 
associated with long dwell time, CVAD dressing changes, and routine catheter care 
(Pathak et al., 2015). Limitations of this study include retrospective design limited to one 
unit with a specific patient population, limiting the generalizability of findings. The large 
sample size is beneficial, but two separate study periods allow for confounding factors.  
Moureau, Sigl, and Hill (2015) performed a 2-site retrospective study to provide a 
descriptive review of two hospital MC programs that were successfully implemented into 
the vascular access practice.  A convenience sample of hospitals included two acute care 
facilities with a MC program including bedside insertion and specific policies in place for 
a period of time greater than two years.  The two participating hospitals submitted 
policies and program outlines for review by the researchers. Vascular access team 
members and leaders from the sites were included as participants in the study. 
Participants were observed and interviewed about program structure, program 
development, device use, barriers and solutions, midline indication guidelines, infection 
rates, and staff education regarding program. Results were used to describe the process 
used to develop a midline catheter program (Moureau et al., 2015).  
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The first site was an urban located 400-bed Magnet hospital, designated as a 
level-1 trauma teaching hospital in the Midwest. The hospital’s infection control 
department had recently provided nurses with a refresher of central line bundle education 
and began evaluating criteria for each patient individually before central line placement.  
The department also introduced the use of ultrasound for difficult access when placing 
PIVs and MCs in an effort to reduce their CLABSI rate (Moureau et al., 2015).   The 
hospital formed a vascular access nursing team to insert PICCs.  A MC protocol, 
instituted to allow MC insertion by the vascular access team without a provider’s order, 
included device selection, patient evaluation, and MC insertion.  When the team 
encountered difficulty with device placement, they adjusted device and manufacturer 
selection and insertion techniques as problems were identified and device insertion 
success rates increased among clinicians. Patients with MCs were assessed daily for 
complications associated with the device and duration of the line dwelling.  Authors 
reported that education of vascular access nurses was critical to success of the new policy 
and practice change (Moureau et al., 2015).  
A 215-bed hospital in Georgia served as the second study site. Hospital 
administrators were concerned with the high number of PICC use in their facility and 
started a MC program.  PICCs were currently placed by the cardiac catheterization team 
at a rate of 60-80 per month.  The facility began the MC program in 2011 and struggled 
with line placement success initially.  After reaching out to the manufacturer’s 
representatives for assistance, they were able to develop consistent placement 
performance with 80-100 MCs placed per month. The hospital’s goal was to increase MC 
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use and reduce CVAD use, remove existing CVADs and replace with MC before the ICU 
patient is transferred to general medical or surgical unit (Moureau et al., 2015).  
The first hospital saw a 58% reduction in PICC use from 2012 to 2014 with 
overall CVAD use down to 0.23/100 device-days from 0.48/100 device-days. The second 
hospital demonstrated an increase from 200 MCs placed in 2012 to 960 placed in 2014.  
Both hospitals considered MC selection as a nurse-driven intervention not requiring 
provider order.  An increase in education of bedside nurses was associated with increase 
in compliance in placing the most appropriate catheter for patients.  Both hospitals 
reported zero MC-associated infections over the study period, and the second hospital 
reported zero CLABSIs in 2014.  CLABSI rates decreased by 78% for the first hospital 
with an estimated cost savings of $531,570.  The authors also noted projected decreased 
costs associated less need for x-ray for placement confirmation, costs for eliminating 
occlusions with thrombolytic medications, and lower insertion costs (Moureau et al., 
2015).  
In both hospitals, vascular access nurse teams were comprised of former 
procedure area nurses and emergency department nurses who participated in training to 
assess and evaluate patients’ long-term access and care needs.  The team ensured that all 
patients had safe access even under difficult circumstances and achieved certification in 
vascular access specialty for all clinicians. Team members educated bedside nurses and 
physicians to promote MC understanding and use and rounded on patients with MCs 
daily to assess access site, dressing, and provide education or intervention when needed 
(Moureau et al., 2015).  
14 
 
The authors note that CVADs in general, without complications, are far costlier 
than MCs and place patients at higher risk for serious complications (Moureau et al., 
2015).  MC program implementation is not without difficulty as noted by the authors, 
insertion techniques can be challenging initially and each hospital made adjustments to 
support users and MC insertion success (Moureau et al., 2015).  This study was limited 
by small sample size and narrow complication reporting focusing on CLABSI alone. The 
participant self-report method limited this study, as recall bias could threaten internal 
validity. 
In a study conducted by Xu et al. (2016) researchers aimed to compare the 
utilization and safety of PICCs compared to MCs. This retrospective study was 
performed at a large academic medical center.  This facility utilized vascular access nurse 
teams to place PICCs and MCs. The study sample included 200 MCs and 206 PICCs 
placed throughout varying inpatient care areas of the facility. Researchers used the 
electronic health record to collected length of stay, VAD dwell time, complications, 
comorbidity score, demographics, and insertion site (Xu et al., 2016). 
Complications were defined as CLABSI, occluded line resulting in 
discontinuation, VAD leaking, pain, edema, or catheter fracture. Serious complications 
were defined as infiltration, phlebitis, or infection resulting in discontinuation of line, 
DVT, positive blood culture, or readmission because of issue related to line. PICC line 
infections were defined using the CDC criteria (CDC, 2019) and MC infections by 
positive blood culture or gross site infection.  Analysis of data was performed using the 
SAS 9.3 statistical package, the Kruskal-Wallis test to explore differences between 
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groups, and Fisher exact test to explain strength of association for categorical variables 
(Xu et al., 2016). 
From a total of 367 patients, 172 had a MC only, 185 had a PICC only, and 10 
had both a PICC and MC during the same single admission (Xu et al., 2016).  Findings 
included 12 total complications associated with PICCs, 10 were serious complications 
including phlebitis, infection, DVT, and positive culture requiring readmission and two 
were not considered serious and related to nonpatency. MCs were associated with a total 
of 39 complications, 18 were serious including phlebitis, infection, DVT, positive culture, 
and infiltration, and 23 were not considered serious including nonpatency, pain, leaking, 
and edema. The difference in severe complications between two groups was not 
statistically significant, but MCs were associated with more complications overall. 
Complications from MCs did not cause any readmissions and 4 readmissions were caused 
by PICC complications (Xu et al., 2016). 
Researchers analyzed readmission rates and complications classified by 
comorbidity score and ICU placement in an attempt to eliminate patient confounders (Xu 
et al., 2016). After analysis, researchers found that minor complications in all hospital 
areas and readmissions, regardless of comorbidity score, were still more likely to be 
associated with MCs than PICCs.  None of the 5 positive blood cultures in MC patients 
were thought to be associated with MCs and 2 of the 5 positive blood cultures in PICC 
patients were reported as CLABSIs. PICCs had a median duration of 12 days and MCs 5 
days. The authors acknowledge a growing concern of administering vesicants, especially 
vancomycin, into MCs.  Thirty-one participants received vancomycin and 3 developed 
phlebitis (Xu et al., 2016). 
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The authors acknowledge that the retrospective design at a single facility during a 
short study duration period and with only one CVAD manufacturer limits the study.  The 
researchers included inpatient complications only, which could have resulted in a 
significant amount of missing complications for the PICC group, as 103 PICC patients 
were discharged with their lines in place while only 3 MC patients kept their line after 
hospital discharge (Xu et al., 2016).  Although the study network is the largest in the area, 
the research was unable to capture readmission to another network facility and could 
have missed complications causing readmission. This can be assumed to be equal among 
groups and does not threaten internal validity. The data was not presented as 
complication per 1,000 catheter days which could have provided a more clear comparison 
of the two groups.  Complication rates could only have been measured if they were 
documented correctly in the electronic medical record.  Errors in documentation can be 
assumed to occur equally throughout groups and therefore do not threaten internal 
validity (Xu et al., 2016).  The authors conclude that MCs are an acceptable alternative to 
PICCs to reduce CLABSI rates, even with the increased potential for mild complications.  
The authors encouraged facilities to report IV access utilization data including patient 
selection criteria to increase comparable data (Xu et al., 2016). 
Vesicant Administration through MC  
A study by Caparas and Hung (2017) aimed to determine the safety and 
effectiveness of administration of vancomycin via MCs. Researchers conducted a 
retrospective chart review of 10,078 patients with MCs from June 2011 to June 2016 to 
determine if vancomycin was administered. The authors found 1,086 patients to have 
received vancomycin and charts were further examined for documentation of 
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complications including infiltration, DVT, CLABSI, and phlebitis. Complications were 
defined appropriately for data collection standardization. All MCs were placed and 
maintained according to current best practice guidelines.  Vancomycin was diluted 
routinely to 4mg/mL and administered at recommended rates (Caparas & Hung, 2017). 
The average age of participants was 73.6 years with 47% of patients being female 
and 53% male. Almost all patients received at least one additional antibiotic medication 
and other IV medications via a MC. Vancomycin doses ranged from 0.5-1 gram 
administrated once or twice per day and 45% of patients received vancomycin for less 
than 6 days duration, 55% for 7-14 days, and 5% for 15-25 days with an average of 7.5 
days (Caparas & Hung, 2017). Every MC was placed in a deep vein of the upper arm, 
except for two lines that were placed mid forearm.  
Researchers found phlebitis documented in six patient records, all instances 
occurred before day 14 of vancomycin administration. Infiltrations were found in 13 
patients, none of which appeared to be serious or requiring additional treatment. Leaking 
was documented in 10 patient charts, none of which were found to have DVT, and 
authors noted that the manufacturer later made changes to line design to prevent leaking. 
No patients were found to have a blood stream infection related to the MC. Ten patients 
had MC removed for an undocumented reason and those patients did not have 
documented DVTs (Caparas & Hung, 2017). 
Researchers conclude that complications occurred overall in 2.7% of patients 
studied with no serious complications including DVTs or blood stream infections.  The 
authors determined their phlebitis findings to be considerably lower than what would 
have been expected, given the pH restrictions placed on MCs.  Findings conclude that 
18 
 
when correctly diluted to 4mg/mL and administered through a MC, vancomycin is not 
associated with tissue destruction with accidental infiltration and is, therefore, not a 
vesicant (Caparas & Hung, 2017). 
The authors go on to predict the potential outcomes and impact on each of these 
patients had a PICC been placed for vancomycin administration. Using the lowest 
complication rate in reported data for PICC utilization, it is predicted that approximately 
16 patients would have developed a CLABSI and one or two may have died as a result 
(Caparas & Hung, 2017).  The authors determine a significant cost savings by avoiding 
CLABSI treatment and using MCs saves about $90 per line.  
Limitations described by the authors include the retrospective study design, and 
suggested a randomized trial comparing PICCs to MCs would be ideal.  Because grading 
scales for infiltration and phlebitis are not typically used at this facility, the researchers 
counted any indication of these complications as a positive finding which could have 
resulted in an overestimate of findings.  This does not impact internal validity as this 
would only result in a bias toward the null hypothesis. Relying on clinical documentation 
alone limits this study as some complications may not have been documented 
appropriately, for example 10 cases were missing documentation of reasons for line 
discontinuation in which potential complications are unknown (Caparas & Hung, 2017). 
VAD Appropriateness Criteria 
 Given the research demonstrating inappropriate and overuse of PICCs, Chopra et 
al. (2015) organized a multidisciplinary team of experts to develop appropriateness 
criteria for the care and management of VADs in hospitalized patients. The team aimed 
to develop a list of indications for PICC placement, define appropriate practice for 
19 
 
insertion and care of PICCs, determine practices for prevention and treatment of PICC 
complications, and rate appropriateness of PIV placement for situations in which a PICC 
was placed.  
 The authors utilized the RAND Corporation/University of California Los Angeles 
(RAND/UCLA) Appropriateness Method (Fitch et al., 2001) to develop appropriateness 
criteria for PICC use (Chopra et al., 2015). The RAND/UCLA method, used to measure 
overuse of medical procedures, establishes a procedure as appropriate when the expected 
health benefits of the procedure exceed the negative consequences significantly enough 
that the procedure is worth performing, regardless of cost.  This method allowed authors 
to synthesize evidence along with consideration of expert practice insights to ensure that 
recommendations will be evidence-based and relevant to practice.  Because available 
evidence on this topic is provided from research conducted in a variety of specialties, 
populations, and study designs, the findings can be misinterpreted and lead to 
disagreements between experts on appropriateness rating for an individual scenario.  The 
RAND/UCLA method simply calls for minimizing these disagreements when making a 
decision, rather than achieving consensus. The RAND/UCLA method produces results 
with high internal validity due to clear definitions and instructions with a systematic and 
reproducible rating system (Fitch et al., 2001). 
 The panel systematically performed the following steps of the RAND/UCLA 
method to develop the appropriateness criteria.  The first step, information synthesis, 
involved systematically reviewing and synthesizing the literature after search of English-
language articles from November 2012 to July 2013 in appropriate databases and 
excluded articles specific to pediatrics or lines that are not comparable to PICCs. 
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Guidelines relevant to the research were included in the literature synthesis. All articles 
were reviewed for eligibility by two authors and disagreements resolved by consensus. 
The second step involved panelist selection in which national and international experts 
representing a variety of areas including vascular access, medicine, surgery, infectious 
disease, critical care, pharmacy, interventional radiology, nephrology, and 
hematology/oncology were invited to participate on the panel with a final recruitment of 
15 panelists.  A patient with experience related to VADs participated on the panel, but 
did not rate scenarios (Chopra et al., 2015). 
 The third step, creation of scenarios, the authors developed clinical scenarios 
based on article findings that were used to rate appropriateness of insertion and 
maintenance of PICCs. The authors compared other VADs including PIVs, MCs, ports, 
and CICCs with PICCs to determine accuracy of clinical decision making around line 
selection. The scenarios were developed to prompt judgment of realistic clinical 
situations and each panelist was asked to provide a list of relevant concerns with PICC 
use to increase validity of this work. A conceptual framework was developed and 
indication for PICC insertion was categorized into duration of access, type of infusate, 
and use for particular reason.  Each clinical scenario incorporated patient specific factors 
including cancer or critical illness, device-specific factors including gauge and number of 
lumens, and provider-specific factors including technique of insertion or provider 
inserting the line. Scenarios related to the use of PIVs and appropriate management of 
PICC complications were also included. All scenarios were pilot-tested with two 
physicians and feedback was used to make edits for clarity. A total of 665 scenarios and 
391 indications for PICCs were developed (Chopra et al., 2015). 
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 The forth step, rating of scenarios and indications, began with each panelist 
reviewing the scenarios without consideration to cost or availability of resources. Each 
scenario was rated on a scale of 1 to 9 with 1 indicating harm outweighs benefit and 9 
indicating benefit outweighs harm. A rating of 5 indications harm and benefits are equal, 
or the panelist could not make a judgment. A rating of 1 to 3 or 7 to 9 indicated 
preference of one device over another and ratings of 4-6 indicated no preference. Each 
scenario was rated twice by each panelist, the first round involved individual rating and 
the second rating was conducted in person with a scientific content expert and 
methodology expert moderating a panel discussion of all scenarios and indications. 
Round two encouraged discussion of scenarios in which ratings were in disagreement or 
neutral. The final step, data processing and analysis, classified indications into three 
categories including appropriate with a median score of 7 to 9, uncertain/neutral with a 
median score of 4 to 6, and inappropriate with a median score of 1 to 3. Disagreements, 
not determined to be appropriate or inappropriate, were defined as at least 5 of the 
panelists rating an indication as appropriate and at least 5 rating the same indication as 
inappropriate (Chopra et al., 2015).  
 Recommendations from panelists are provided based on situation (Chopra et al., 
2015).   For hospitalized medical patients receiving an infusion of peripherally 
compatible infusates, line appropriateness is based on expected duration of infusions.  For 
a duration of 5 days or fewer a PICC was rated inappropriate, for a duration of 6 to 14 
days a PICC was rated appropriate, but preference for MC or USGPIV was indicated as 
the preferred VAD.  Panelists preferred PICCs to MCs for a duration longer than 15 days 
but recognize that MCs may be used for up to 4 weeks.  For administration of vesicants 
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including total parenteral nutrition (TPN) and chemotherapy that are not compatible with 
peripheral administration, PICC is appropriate for all durations. Panelists could not agree 
on placement of PICCs for frequent blood samples or difficult venous access for duration 
of use less than 5 days. After panelist discussion, recommendations include 
considerations on an individual basis with discussion between patient and provider about 
options, risks, and benefits (Chopra et al., 2015).  
 For patients with chronic kidney disease (CKD) stages 1 to 3a, PICC 
recommendations should align with those of standard hospitalized patients, but panelists 
acknowledge other individual CKD patient factors including blood pressure, age, race, 
and magnitude of albuminuria that may impact progression of renal disease and 
ultimately recommend consultation with nephrology before considering PICC insertion if 
severity of underlying kidney disease is indefinite. The panelists rate PICCs and MCs as 
inappropriate for stage 3b CKD patients and stress the importance of preserving 
peripheral and central veins for potential hemodialysis and creation of arteriovenous 
fistulae and grafts for these patients. The panelists again recognize the need to address 
individual patient situations including urgency of venous access need and availability of 
resources. For cancer patients when considering the increased risk for thrombosis and 
consequences of infection, PICCs were rated as appropriate only if the duration of 
treatment was three months or fewer (Chopra et al., 2015). 
 For critically ill patients, PICCs were rated as inappropriate for less than 15 days 
of infusing peripherally compatible medications (Chopra et al., 2015). PIVs were rated as 
appropriate for fewer than 5 days and MCs appropriate for durations of 6 to 14 days of in 
this population. PICCs were rated as appropriate for hemodynamically unstable patients 
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when central access or hemodynamic monitoring was required. CICCs were preferred to 
PICCs for urgent situations.  Panelists rated PICCs as appropriate for palliative treatment 
during end-of-life care. Panelist recommendations for appropriate PICC practices include 
consulting relevant specialists as needed for guidance before ordering a PICC.  Single-
lumen PICCs of the smallest gauge are recommended unless indication for multi-lumen 
PICC placement is met (Chopra et al., 2015). 
 Appropriate PIV practice recommendations include the use of ultrasound 
guidance for placement of PIVs in patients with difficult venous access with duration of 
treatment of 5 days or less. Remove PIVs when swelling, redness, or phlebitis is present 
at insertion site. PIVs should not be removed, regardless if line was placed outside of the 
hospital, on a routine schedule and should only be rotated when clinically indicated by 
insertion site complications. Routine placement of PIVs without clinical indication is 
inappropriate (Chopra et al., 2015). 
 The authors combined existing evidence with expert review to develop 
appropriate indications for use of VADs to decrease inappropriate placement and risk of 
preventable complications in hospitalized patients. The guidelines provided offer patient-
specific considerations to help clinicians make the most appropriate decisions in complex 
patient situations. The authors recognize the challenges clinicians may still encounter 
with VAD selection as it is difficult to predict duration of treatment and time constraints 
may limit ability to fully consider options and weigh risks and benefits. The study is 
limited by the exclusion of neonatal and pediatric studies when developing 
recommendations, but the authors recognize the need for similar work for these 
populations. The study panel did not include bedside nurses, but vascular access nurses 
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were represented. Applicability of these recommendations may vary by organization and 
provider given available resources, competency, and education (Chopra et al., 2015). 
Vascular Access Nurse Teams  
The relatively new specialty of vascular access nursing is comprised of nurses 
who are trained to specialize in insertion, maintenance, and monitoring of vascular access 
in hospitals.  Chopra et al. (2016) surveyed vascular access nurses across 47 Michigan 
hospitals to explore their knowledge, beliefs, practice, and experience related to PICC 
utilization and management.  The web-based survey was administered to purposeful 
sample of vascular access nurses.  The survey instrument, PICC1, was developed by the 
researchers through a literature review of evidence-based guidelines and studies 
pertaining to vascular access nurses’ practice.  Leaders in vascular access nursing 
provided consultation to ensure validity of the questions. The survey was pilot tested with 
nurses outside of the sample group and refined based on feedback and tested again by 
members of the research team. The survey collected basic demographic data and assessed 
nursing background, practices, types of devices used, technologies used, management of 
complications, and relationships with providers (Chopra et al., 2016).  
The survey received 140 responses, an 81% response rate, with 95% of 
respondents reporting that they place the majority of PICCs at their hospital, 23% 
reported holding a vascular access certification (Chopra et al., 2016).  Ninety-five percent 
of respondents reported that their hospital had written policies for standard care of PICCs, 
and 30% reported having policies regarding the appropriateness or necessity of PICCs.  
Participants reported the most common indications for PICC use as intravenous 
antibiotics at discharge, difficult venous access, and chemotherapy. Forty-six percent of 
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participants reported placing a PICC in a patient receiving dialysis, but 91% reported 
receiving approval from nephrology before device placement. Ninety-eight percent of 
respondents reported that they were not able to remove unnecessary PICCs without 
physician approval.  Two-thirds of vascular access nurses surveyed reported relationships 
with bedside nurses and providers to be very good or good. Fifty-one percent of 
respondents described leadership support as excellent, very good, or good while 43% 
perceived leadership as fair or poor (Chopra et al., 2016). 
 Researchers found that indications for PICC placement aligned with evidence-
based indications in the literature, but the frequency of use in dialysis patients was 
surprisingly high given the recommendations to avoid use of PICCs in these patients 
(Chopra et al., 2016).  The researchers found variations in placement and management of 
PICCs that indicates a need for disseminating relevant literature to promote consistent 
practice. Results demonstrated that a large portion of vascular access nurses felt that 
some PICCs were unnecessary and were placed without appropriate clinical indication. 
Reported positive relationships with bedside nurses and providers indicates that 
interventions to improve care involving collaboration with these partners could be highly 
effective.  The researchers acknowledge a limitation in the survey sample as all 
respondents are employed at hospitals that are engaged in improving PICC practices, 
indicating that this group may be disproportionately motivated in this area and is not 
necessarily representative of all vascular access nurses (Chopra et al., 2016). 
 Chopra et al. (2017) distributed the web-based survey, PICC1, to vascular access 
nurse specialists, to members of the Infusion Nurses Society and the Association for 
Vascular Access to assess training, experiences, and practices of these specialists. A total 
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of 1698 vascular access nurses completed the survey with representatives from all 50 US 
states and 4% practicing outside of the US. Eighty-three percent of respondents reported 
that vascular access nurses were responsible for placing most of the PICCs at their 
facility and 76% of all participants worked in inpatient settings. Most participants, 92%, 
reported that PICC placement rates are tracked at their facility, but only 61% reported 
that dwell times of PICCs are monitored.  Almost all participants reported that their 
facility had policies regarding PICC insertion and care, however only 63% had a policy 
to review necessity of PICCs that are in place.  For participants at facilities with necessity 
review policies, 45% reported this review was performed by the bedside nurse, 32% by 
the providers, 32% by a multidisciplinary approach, and 23% by vascular access nurses 
on daily rounds. Twenty-three percent reported that vascular access nurses could remove 
an unnecessary PICC without provider approval (Chopra et al., 2017).  
 The most common indication for PICC placement reported was antibiotic 
treatment after discharge followed by difficult venous access and administration of total 
parenteral nutrition (Chopra et al., 2017). Fifty-eight percent of participants reported 
placing PICCs in dialysis patients, but 91% stated they received approval from a 
nephrologist before placement. Forty-two percent of vascular access nurses surveyed 
reported that more than 10% of PICCs placed at their facility were inappropriate or 
avoidable.  Relationships with providers were reported as good or very good by 73% of 
respondents and 78% reported good or very good relationships with bedside nurses. 
Support from facility leadership was reported as good or very good by 36% and poor or 
fair by 36% of vascular access nurses (Chopra et al., 2017). 
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 Survey results demonstrate variation in vascular access nurses’ perception of 
appropriateness of PICC placement as well as support of leadership at their facilities 
(Chopra et al., 2017).  The authors hypothesize that variation in practice among these 
specialists is likely related to the limited high-quality evidence and best practice 
recommendations available to guide practice.  Implementation of MAGIC guidelines is 
recommended to ensure the latest evidence and expert opinion is utilized to address best 
practices for the use of PICCs and other VADs in a variety of patient scenarios. It is 
likely that many vascular access nurses have not yet incorporated the latest evidence into 
practice, which highlights the need to additional training, education, and certification in 
this specialty. The authors acknowledge the limitations of the convenience sample 
including selection bias and nonresponse to the survey (Chopra et al., 2017).  
Role of Vascular Access Nurse Teams 
 Krein et al. (2017) conducted web-based surveys to explore the function of 
vascular access nurses in a healthcare team, the perceived role of nurses in this specialty, 
and how their practice could relate to appropriateness of PICC use in hospitals.  The 76-
question survey was developed by the study team and pilot tested by several nurses 
before distribution by e-mail to all 8300 members of both the Association for Vascular 
Access and the Infusion Nursing Society.  The survey focused on vascular access nurses’ 
relationships with bedside nurses and providers, hospital policy and practices regarding 
PICC use, and their perceived role as specialists bringing value to practice.  The final 
sample size of 1147 vascular access nurses resulted from excluding respondents who did 
not identify as vascular access nurses and those who practiced outside of a hospital 
(Krein et al., 2017).   
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 Results indicated great variability in the perceived role of vascular access nurses 
in relation to PICC use in hospitals (Krein et al., 2017). Perceived function in their role 
varied greatly between functioning as operators, simply performing the technical function 
of line placement, to specialized consultant roles, providing expert recommendations. 
Among those who viewed their role as specialized consultants, perceived variations in the 
value of their recommendation among providers and bedside nurses emerged.  Vascular 
access nurses who felt that they are valued consultants reported better relationships with 
other members of the care team than unvalued consultants and operators (Krein et al., 
2017). 
 Valued consultants reported higher rates of safety practices with PICCs at their 
facilities, including tracking PICC placement and dwell time data and lower rates of 
inappropriate use of PICCs and inappropriate device removal. Hospitals with vascular 
access nurses who perceive their role to be consultants with value-added contributions to 
decision making have a lower frequency of inappropriate PICC use. Vascular access 
nurses who felt they were valued consultants had more experience in practice and placing 
PICCs than the other two role groups (Krein et al., 2017).  
 Survey findings demonstrated, in U.S. hospitals, the majority of PICCs are placed 
by vascular access nurses (Krein et al., 2017).  Results from the research indicate that 
understanding how to promote interprofessional collaboration is critical to ensuring 
improved appropriateness of PICC use in hospitals with vascular access teams. Further 
research is needed to understand the association between the perceived role of the 
vascular access nurse and device utilization practices.  Selection bias is a potential threat 
to findings given the sampling process. There is potential for response bias as all findings 
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are based on self-report from nurses and question interpretation could be a factor. There 
may not be an association between perceived role and appropriate PICC use as more 
satisfied nurses may be more likely to report more favorable practices (Krein et al., 
2017). 
 Overall, findings suggest that vascular access nurses’ perceived role influences 
PICC use in hospitals and improved interprofessional collaboration improves PICC 
utilization. An environment that allows for vascular access nurses to use their expertise in 
the specialty to make valued recommendations for line selection is a necessary 
component in improving PICC use (Krein et al., 2017).  
Healthy Work Environment 
The American Association of Critical Care Nurses Standards for Establishing and 
Sustaining Healthy Work Environments (2016) were developed in response to evidence 
correlating unhealthy health care work environments to stress for health care 
professionals, specifically nurses.  Unmanaged stress in an organization lacking support 
for professionals can lead to medical errors and ineffective care delivery.  The AACN 
maintains that the six essential standards, skilled communication, true collaboration, 
effective decision making, appropriate staffing, meaningful recognition, and authentic 
leadership, must be in place to ensure a healthy work environment exists that will support 
professionals to deliver high-quality, safe patient care (AACN, 2016).  
According to the AACN (2016), skilled communication is as important for 
successful nursing practice as clinical skills.  Skilled communication involves a dialogue 
among interprofessional team members that promotes collaborative thinking and 
decision-making.  Effective communication supports mutual respect among team 
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members and supports finding solutions and achieving shared goals (AACN, 2016).  True 
collaboration is an ongoing practice among teams who understand and embrace the 
strengths and expertise of professionals on the team.  The complex needs of patients and 
families cannot be adequately met without true collaboration in which each discipline is 
sharing knowledge and working together toward the common, patient-centered, goal 
(AACN, 2016).   
As advocates for the best interests of patients and families, nurses must be equal 
partners with other members of the interdisciplinary team to facilitate effective decision-
making.  Nurses must work to close the autonomy-accountability gap to maximize their 
contribution to care discussions and decisions (AACN, 2016).  Appropriate staffing ratios 
that address varying patient needs and nurse specialty knowledge and expertise are 
important to high-quality care delivery within a healthy work environment (AACN, 
2016).  As a valued member of the interprofessional team, nurses must be recognized for 
their unique commitment to patient care.  A healthy work environment cannot exist 
without a culture of meaningful recognition that acknowledges the contribution of each 
member of a diverse team (AACN, 2016).  
To develop and maintain a healthy work environment, nurse leaders must engage 
team members in the process and fully embrace the culture (AACN, 2016).  The AACN 
supports the need for qualified nurse leaders prepared as change agents, team builders, 
and role models for collaboration to create this environment in a health care organization.  
The leader must be innovative and understand that sustained success of a healthy work 
environment involves support for ongoing education and coaching of team members to 
develop interprofessional collaboration skills (AACN, 2016).   
31 
 
Interprofessional collaboration is best supported by health care organizations that 
evaluate team member accountability and address willingness to collaborate 
appropriately, with an emphasis on incorporating the decision-making authority of nurses 
(AACN, 2016).  Nursing leadership, in an organization committed to delivering the 
highest quality patient care, will support clinical nurses as professionals and encourage 
participation in education and coaching opportunities that will further develop the 
collaboration skills necessary to maximize efforts of the interprofessional team (AACN, 
2016).  These standards support the need for a healthy work environment to promote high 
quality care in response to the variety of challenges facing healthcare professionals in the 
increasingly complex and rapidly changing environment in which care is provided 
(AACN, 2016).  
Clinical Decision Support  
Increasing the availability of evidence-based support tools at the point of care to 
allow clinicians align care decisions with evidence can enhance quality of care and 
decrease health care costs (Nelson & Staggers, 2018).  Using an informatics-based tool to 
redesign the methods in which care is provided can close the gap between evidence and 
practice.  When considering the large amount of research conducted in health care every 
year, it is evident that most clinicians would find it nearly impossible to read all relevant 
research published on a variety of necessary topics and translate findings into applicable 
practice recommendations.  If a clinician should select the best plan of care that will be 
most effective for a patient, their decision should be supported by all best available 
evidence (Nelson & Staggers, 2018). 
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Clinical decision support (CDS) systems, described in research provided on the 
Agency for Healthcare Research and Quality (AHRQ) Health Care Innovations 
Exchange, use automation and informatics-based tools to bring evidence to the point of 
care for clinicians (Berner, 2009).  CDS incorporates patient-specific information from 
the electronic medical record with clinical guidelines and best evidence to provide 
clinicians with pertinent information to make clinical decisions for patients that are 
aligned with the most recent pertinent findings.   
According to the AHRQ Health Care Innovations Exchange, CDS systems have 
the ability to improve quality of care in many ways including preventing dangerous drug 
interactions, improving appropriateness of antibiotic therapy choice, and increasing use 
of recommended therapies for treatment of chronic conditions (Berner, 2009).  There are 
many factors that enhance or disrupt the impact and effectiveness of the CDS system 
including timing of reminders, delivery of information, and user control over CDS 
recommendations.  A needs assessment, purchasing plan, design plan, implementation 
process, and evaluation plan must be performed before a CDS system can be incorporated 
into a workflow process.  A CDS system must be maintained and evaluated through data 
collection to understand the impact on care and identify potential areas for improvement.  
To achieve optimal outcomes with CDS system use, the tool must be specifically 
designed to meet the needs of the patients and users to improve quality of care and 
efficiency (Berner, 2009).  
CDS can improve safety and quality of care by bringing the highest level of 
evidence available directly to clinicians to support clinical decision making in practice 
(Berner, 2009).  When implemented and utilized appropriately, CDS can be used by 
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clinicians to apply the evidence-based knowledge to a unique patient scenario to provide 
clinical suggestions for considerations by the clinician. Knowledge-based CDS can assist 
clinicians to apply clinical guidelines to patient specific data to suggest best practices.  
CDS applications typically involve the use of technology-based systems that allow for 
combining knowledge with necessary patient specific information to produce a 
meaningful recommendation to the clinician to support decision making (Berner, 2009).   
CDS systems can impact clinical decisions in a variety of ways and through 
different approaches. User control and autonomy of decision making when using these 
systems can range from automatic notifications that clinicians can determine to ignore or 
follow to systems that are accessed by demand from the user when needed. CDS systems 
are most successful when users are able to easily access these resources with minimal 
disruption to workflow processes (Berner, 2009).  User willingness and motivation to use 
CDS systems are crucial to integrating these processes.  Implementation of new CDS 
systems, which alter routine practice, can create resistance among users especially if 
clinicians perceive the CDS system to limit desired autonomy and require additional time 
to use (Berner, 2009). 
Research by Cortez, Dietrich, and Wells (2016) performed a cluster randomized 
trial to test a new CDS system integrated into the nursing electronic documentation 
software and determine the impact on an evidence-based nursing intervention. The CDS 
offered evidence-based information to nurses in drop-down boxes available during 
decision making processes. The researchers evenly divided four adult oncology clinic 
sites into two groups, one control without CDS group and one intervention with CDS 
group.  Researchers measured the outcome of documentation of the evidence-based 
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intervention.  A symptom documented by a nurse in the intervention group prompts the 
nurse to have a conversation with the patient, noting the evidence-based intervention for 
that symptom (Cortez et al., 2016). 
A statistically significant effect was demonstrated, comparing the rate of 
evidence-based nursing intervention after education session.  This increase in evidence-
based intervention rate did not sustain in either group, demonstrating that the CDS itself 
had no positive effect on the intervention rate (Cortez et al., 2016).  The authors 
concluded that CDS implementation designed to increase evidence-based practice among 
nurses requires support strategies, like audit and feedback, to be successful.  The authors 
also note the distinction of evidence-based documentation practices between nurses and 
physicians.  Medical research related to CDS implementation with outcome measures 
involving evidence-based practice documentation may be more successful with 
physicians as this type of documentation is often tied to reimbursement and 
communication among the care team for physicians.  Nurses may not perceive their 
documentation as valuable to the care team communication and it is not tied to 
reimbursement, so these motivating factors for documentation are not present.  Lack of 
perceived value in documentation may have resulted in intervention practices that were 
not captured simply because they were not documented (Cortez et al., 2016).  
Utilizing MAGIC to Guide Practice 
 Swaminathan et al. (2018) utilized the MAGIC evidence-based guideline to 
determine if utilizing decision-making criteria can improve appropriateness of PICC use 
and decrease complications associated with CVADs in hospitalized patients.  The 
intervention site was a 600-bed community teaching hospital that was collected data on 
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patients with PICCs.  The sample included all adult patients admitted to an ICU or 
general care unit who received a PICC for any reason.  Trained abstractors retrieved data 
from the medical records of subjects beginning at PICC placement and ending at PICC 
removal, death, or when 70 days of data collection had been reached. Data collected 
included patient characteristics, appropriateness measures, device-related complications, 
number of PICCs including number of lumens, number of MCs, and patient days. Data 
was collected for one year pre-intervention and one year post-intervention (Swaminathan 
et al., 2018). 
 The MAGIC-based intervention included a tool to evaluate appropriateness of 
PICC placement before insertion, nurse training on MAGIC recommendations, electronic 
medical record changes to incorporate the recommendations, and provider education 
pertaining to the MAGIC recommendations. The vascular access nurse team used a 
standardized method to evaluate each PICC order for appropriateness based on the 
MAGIC criteria.  The team determined if the PICC order was appropriate based on 
indication, proposed duration, and the nature of the infusate to be administered. If 
determined to be appropriate, the PICC was placed as ordered, if inappropriate the team 
discussed alternative device options with the ordering provider (Swaminathan et al., 
2018). 
 The vascular access nurses were provided with a 4-hour education session that 
involved ultrasound training and education regarding peripheral alternatives to PICCs.  A 
collaborative team established changes to the electronic medical record that allowed 
pharmacists to highlight infusate orders that required central lines or multiple lumens.  
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Nine peer hospitals were utilized as an external control to account for trends in vascular 
access device selection (Swaminathan et al., 2018).  
 Results of the study found PICC use decreased significantly and MC use 
increased after MAGIC implementation (Swaminathan et al., 2018). Multi-lumen PICC 
use decreased after implementation and single-lumen PICC use increased. The 
researchers found a significant decrease in inappropriate PICC use at the study site, but a 
smaller, yet significant, decrease in inappropriate PICC use was found at the control sites. 
The greatest impact on PICC use was demonstrated in the categories of PICC use for less 
than 5 days and PICC use for less than 14 days in the ICU. The rate of serious 
complications, included DVT and CLABSI, did not decrease significantly when 
compared to the control sites, but this could be contributed to overall low rate of these 
complications. The authors were able to conclude that implementation of MAGIC criteria 
led to a modest improvement in PICC use as a small, but significant, improvement was 
seen when compared to the control sites (Swaminathan et al., 2018).  
 The authors note a significant cost associated with conducting this study and a 
reasonable return on investment.  Recommendations for future quality improvement 
initiatives of this kind include careful consideration to cost-benefit ratio.  The authors 
acknowledge limitations to this research including the single study site and which limits 
generalizability.  The study methodology included multiple pieces, making it difficult to 
determine which part of the intervention, if any, was most impactful.  Knowing the most 
impactful intervention could guide future research and quality improvement initiatives in 
this area (Swaminathan et al., 2018). 
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Theoretical Framework 
Lewin’s Change Theory and the Synergy Model for Patient Care are the 
theoretical models used to guide this quality improvement project.  
Lewin’s Change Theory  
A social psychologist of the 20th century, Kurt Lewin, developed the force field 
analysis as a framework for examining the factors that influence a situation.  In this 
theory, a field is seen as a system, which must be completely explored after a change is 
made to determine its effect.  A force’s balance is disrupted during change.  A force field 
analysis establishes two forces, the driving forces that encourage movement to a new goal 
and restraining forces that impede progress toward the outcome.  Force field analysis 
framework forms the foundation of Lewin’s 3-stage theory of planned change (McEwen 
& Wills, 2011).  For planned change to be effective, driving forces should be identified 
and emphasized and restraining forces should be minimized.  Effective change is 
described by Lewin as a return to equilibrium resulting from a balance of forces.  
Identification of these forces could predict when change will be effective (McEwen & 
Wills, 2011). 
The first stage, unfreezing, involves preparing for change.  This stage includes a 
change agent identifying a problem and a need for change and then informing others of 
the need for change.  The change agent needs to emphasize the necessity of the change 
and choose a solution to prepare for the next phase.  For planned change to be effective, 
driving forces should be identified and emphasized and restraining forces should be 
minimized (Lewin, 1951).  
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The second stage, movement, involves examining change as a process and 
recognizing individuals moving to a new way of being.  Change, especially in healthcare, 
can cause feelings of uncertainty and stress in individuals involved, so individuals need 
encouragement to try out the change (McEwen & Wills, 2011).  The change agent should 
move through the change process gradually and thoughtfully, recognizing that change 
does not happen quickly.  For successful change, resistance should be anticipated.  
During this phase driving forces should exceed restraining forces.  Coaching and 
guidance during this, often challenging, phase is required to move individuals to the 
revised process (Lewin, 1951).  
The third stage, refreezing, requires stabilization of the change so that it can 
sustain.  The change agent must neutralize restraining forces that are hindering change 
and emphasize driving forces to continue to stimulate change.  If the change is 
successfully fixed into practice, equilibrium is restored, and the change is effective and 
will continue as the new standard (McEwen & Wills, 2011).  In introducing a new 
evidence-based guideline, nurses’ perceived usefulness of the guide is motivation for the 
sustained success of this tool in practice. 
Lewin’s theory of planned change considers the process of prepared change and 
when the described 3-stage process is used correctly, effective change is achieved.  This 
theory is best utilized in stable environments when there is adequate time to create 
change.  Although this theory is one of the oldest in change management, it is efficient 
and easy to use and understand.  These qualities allow this theory to be used often in 
healthcare, especially in nursing administration and education, and is considered to be 
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most effective when a top-down approach, in which senior leaders drive change is used 
(McEwen & Wills, 2011). 
The Synergy Model for Patient Care 
The American Association of Critical-Care Nurses (AACN) developed the 
Synergy Model for Patient Care in the early 1990s to describe nursing practice, especially 
the unique contribution of critical care nurses.  The goal of this model development was 
to describe the distinct skills that nurses bring to patient care while meeting the needs of 
patients and families (Hardin, 2013).  This conceptual framework emphasizes nurse 
competencies that are driven by patient characteristics. The underlying concept of this 
model explains that optimal patient outcomes are more likely to occur when patient 
characteristics and nurse competencies are in synergy (Curley, 2007).  
The Synergy Model recognizes the unique characteristics that each patient and 
family bring to a clinical scenario.  These eight characteristics include stability, 
complexity, predictability, resiliency, vulnerability, participation in decision making, 
participation in care, and resource availability (Hardin, 2013). This model established 
eight nurse competencies including advocacy, clinical judgment, caring practices, 
collaboration, response to diversity, systems thinking, clinical inquiry, and facilitator of 
learning to explain nursing practice (Hardin, 2013).  The characteristics for nurses and 
patients are ranked on a five-point Likert scale with 1 representing the novice nurse to 5 
ranking expert level and 1 representing the worst patient situation to 5 as the most ideal, 
respectively. The patient characteristics describe what is consistently observed in the 
acute and critically ill patient population and the nurse characteristics are considered 
competencies required for caring for the described patients (Hardin, 2013). This model 
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explains how the complex integration of skills, knowledge, and attitude by nurses meets 
the unique needs of patients to maximize patient outcomes (Curley, 2007).   
The Synergy Model describes nursing practice in caring for acute and critically ill 
patients in a hospital setting. This model is clear and easy to understand because the 
language used is consistent with terms common to healthcare settings.  The patient and 
nurse characteristics are appropriately described so that any healthcare professional with 
basic knowledge of care for acutely ill patients can understand and apply this theory.  The 
model displays a consistent approach to nurse and patient characteristics with equivalent 
scales and similar terms used to explain all components (Smith, 2013). 
The Synergy Model is unique in that it was created for a specific nursing 
specialty, critical care, and was developed by a group of specialists from the nursing 
profession (Smith, 2013).  Development of this model is logical, as its foundation simply 
states that when a nurses’ skills and experience meet the unique needs of a patient and 
family, the patient will benefit from optimal outcomes (Stewart, 2018). The AACN 
developed this model in an attempt to explain how the complex art of nursing is more 
convoluted than the often-perceived practical actions of following a standard order set 
developed through a medical model (Hardin, 2013). This broad conceptual model 
explains how connecting patients with nurses that are best equipped to meet their unique 
needs will create a synergistic effect, meaning better patient outcomes are likely. The 
Synergy Model is not specifically predictive of outcomes and remains general in its 
assumptions (Smith, 2013).  
The Synergy Model has an obvious focus on the important relationship between 
patients and nurses. The authors of this model believe the reciprocal nature of the nurse-
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patient connection is unique and enhances the contributions made by the nurse to care 
(Hardin, 2013). The 16 characteristics described are simple and straightforward to guide 
readers to utilize this model and create optimal nurse-patient relationships. The 
underlying concept of this model is especially simple, as nurses with specific skills and 
attitudes matched with the unique characteristics of patients will likely result in optimal 
patient outcomes.  This model correlates closely with clinical nursing practice in both 
acute and critical care settings (Smith, 2013). 
The AACN Synergy model has shown to be broad and applicable to many other 
settings as well. The model has been utilized in outpatient settings, specifically to 
understand and manage the complexities of outpatient congestive heart failure patients 
(Smith, 2013). This model may have been developed specifically for nurse-patient 
relationships in critical care, but characteristics could be applicable to other disciplines.  
The nurse characteristics described may not be unique to nurses as many other healthcare 
professionals use these skills in patient care, but the complex utilization of all 8 
characteristics driven by a patients’ individual state is likely unique to nursing alone 
(Smith, 2013). 
The Synergy Model has been utilized across critical care areas in a variety of 
ways, defining requisite of nurse skills to guiding preceptor programs for new nurses. In 
addition, this broad framework has been utilized to develop acuity tools for medical-
surgical units and to support development of a staffing tool to ensure safe transport of 
patients between hospitals (Stewart, 2018).  The Synergy Model is easy utilized 
frequently in research and education in describing phenomenon unique to nursing 
practice.  
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The Synergy Model is consistently useful across nursing roles and settings.  From 
acuity tools developed from this model used by a clinical charge nurse making an 
appropriate patient care assignment to a critical care nurse educator using this model to 
develop a preceptor program for new nurses. The clear explanation of concepts in the 
model make it ideal for bedside nurse implementation.  The models’ explanation of 
nursing complexities overall creates an ideal situation for use as a framework for practice 
development by nursing leadership (Smith, 2013).  This model appears to be broader than 
many other middle range theories as it addresses all major concepts of nursing, although 
the model was originally developed to be limited to acute and critical care inpatient 
nursing.  The model appears to be narrow as it is easily applicable to practice, but the 
successful use of this model beyond the hospital has shown it to have a larger scope than 
initially intended (Smith, 2013).  
Through introduction of a new evidence-based guideline to drive nursing practice, 
this project uncovers unanticipated complexities of nursing practice that impact the 
vascular access nurses’ utilization of this guide.  Although the MAGIC guideline may 
appear straightforward and easily applicable to any acute care patient, the unique 
complexities of the patient-nurse relationship may impact use of the guidelines in 
practice.  The AACN Synergy Model and Lewin’s Theory of Change will be utilized to 
understand and articulate barriers to guideline utilization as a standard across all acute 
care patients.  This project unleashes understanding into the complexity that is nursing 
care in terms of standard guideline use for acute care patients. 
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Project Objectives 
 
The proposed project objectives included implementing an evidence-based 
decision support tool for use by the vascular access nurse team to improve 
appropriateness of VAD selection for hospitalized adult patients at a large academic 
medical center.  Decision support guidelines were composed of evidence-based 
recommendations from available MAGIC resources (Appendix A-D).  The algorithms 
implemented address complex patient scenarios that challenge clinicians, specifically 
vascular access nurses, when determining the most appropriate VAD for a patient. 
Project goals included improving appropriateness of VAD selection with 
recommendations from vascular access nurses using MAGIC evidence-based guidelines 
in clinical decision making.  Achieving these goals could result in a decrease in CVAD 
use and a reduction in serious complications associated with CVADs. Objectives are 
aimed at improving the quality of patient care by using the latest evidence for vascular 
access recommendations for appropriateness. Improved quality of care can reduce health 
care costs by preventing complications that prolong length of stay for patients and require 
additional treatment. 
Methods 
The purpose of this quality improvement project was to equip vascular access 
nurses with the MAGIC evidence-based guidelines and knowledge necessary to support 
clinical decision making in VAD selection.  The project was conducted at an urban, 700+ 
bed academic level 1 trauma medical center with a dedicated vascular access nurse team. 
The target audience for the project includes a specialized vascular access nurse team.  
This team, composed of 15 vascular access nurses, was informed about the project 
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through email and informational posters and given the opportunity to participate.  The 
participants attended a one-hour focus-group education session (Appendix E) conducted 
by this author to obtain the MAGIC evidence-based guidelines and knowledge necessary 
to utilize this decision criteria in practice.  In this session, the participants were provided 
with the MAGIC evidence-based resources (Appendix A-D) for use.  Education content 
was designed to prepare the vascular access nurses to utilize the MAGIC resources to 
make recommendations for VAD selection for adult patients.  The vascular access nurses 
were provided with printed MAGIC resources (Appendix A-D) to carry as reference 
cards in the clinical setting.  
The vascular access nurses were asked to complete the Role in VAD Selection 
Pre-Survey (Appendix F), developed by this author, to measure perceived comfort in 
their role when making VAD recommendations based on available evidence.  The 
MAGIC Criteria for VAD Selection Pre-Assessment (Appendix G), developed by this 
author based on key content from the MAGIC guidelines, was conducted before the 
education session to measure baseline knowledge of device selection criteria.  The 
MAGIC Criteria for VAD Selection Post-Assessment (Appendix H), developed by this 
author based on key content from the MAGIC guidelines, was conducted after the 
education session to measure knowledge and understanding of use of the MAGIC 
guideline in clinical scenarios.  
During the three-month data collection phase of the project, vascular access 
nurses responded to requests and orders from providers and bedside nurses for VAD 
placement and assessed appropriateness for the requested VAD using MAGIC evidence-
based guidelines provided.  Vascular access nurses discussed device selection criteria 
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with the provider or primary nurse and recommended the most appropriate VAD given 
patient characteristics and the MAGIC evidence-based guidelines.  Vascular access 
nurses completed the MAGIC Criteria for VAD Selection Data Collection Tool 
(Appendix I), developed by this author with input for revisions from two vascular access 
nurse champions, to capture the impact of vascular access nurse recommendations on 
VAD placement.  Data collection tools were deposited by vascular access nurses in a 
secure envelope in their department at the end of their shift.  The Role in VAD Selection 
Post-Survey (Appendix K) was administered to vascular access nurses at the end of the 
project to measure a change in perceived comfort in their role when making 
recommendations for VAD selection.  
The entire vascular access nurse team was trained by the facility to use ultrasound 
for VAD placement within one year of this projects’ education session date.  Data 
collected by the vascular access team was analyzed using descriptive statistics.  All data 
was stored in a locked area that was accessible by this student and the primary 
investigator only.  
Resources, Support, Risks, Threats 
Strengths of the proposed project include the organization’s designated vascular 
access nurse team consisting of nurses trained and certified in this specialty. This team 
places nearly all of the PICCs, MCs, and USGPIVs in the facility and works together to 
meet all of the inpatient vascular access needs.  This small team works collaboratively 
and shares difficulties with practices and suggestions for improvement among the group. 
This team has available technologies and resources including ultrasound to assist with 
difficult VAD placement.  The vascular access team services all inpatient areas of the 
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hospital, which is a strength for reaching the proposed change to patients in all 
specialties.  
This proposed project site is currently on the journey to Magnet designation.  
Nursing leadership within the organization is strongly motivated to utilize evidence-based 
practices to improve the quality of care for patients.  Nursing leadership supports 
innovative ideas from bedside clinicians as these practitioners are closest to patients and 
have the potential for great impact.  
This organization may fall short in MC and USGPIV appropriateness of use with 
underutilization and PICC appropriateness of use with overutilization. The current 
research demonstrates that MCs are underused and PICCs are over used and 
inappropriately used in inpatient care in similar settings (Chopra et al., 2015). The large 
size of this institution, including many individually functioning units and patient care 
areas, is a vulnerability for this project as there is an opportunity for areas to be unaware 
of evidence-based recommendations.  Underutilization of MCs may be correlated with 
previous failed attempts to implement more frequent use and misconceptions about the 
appropriateness of use of these devices.  Literature suggests that many MC programs 
have been initiated and subsequently fallen out of popularity due to misconceptions about 
their appropriateness for use (Pathak et al., 2015). 
The expected overuse of PICCs and other CVADs places patients at risk for 
serious and costly complications.  According to MAGIC recommendations, (Chopra et 
al., 2015)  serious complication risk can be  anticipated to nearly eliminated risk in 
patients who receive a MC, USGPIV, or PIV in place of a CVAD.  This is an opportunity 
for improving patient outcomes and decreasing vascular access related health care costs 
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for this population. Frequent attempts to place a PIV can be painful for patients and cause 
fear and distress contributing to decreased satisfaction with care.  Replacing PIVs with an 
USGPIV or MC for patients who meet the criteria for a longer duration of access can 
reduce access attempts and create an opportunity for an increase in patient satisfaction 
scores.  Reduced vascular access attempts can decrease additional time spent on multiple 
access attempts and increase nurse satisfaction.  
The mission, vision, and values of this organization clearly prioritize high quality 
care, use of innovative technologies, and a collaborative approach to ensure optimal 
patient outcomes.  The proposed project is designed to utilize the latest research and 
evidence-based recommendations to decrease serious complications for patients and 
improve outcomes in a cost-effective manner.  This project involves collaborative work 
with a specialized vascular access nurse team to implement best practices to improve care 
and aligns well with the mission, vision, and values of the organization.   
Expected Outcomes/ Evaluation & Dissemination Plan 
 
 Providing decision support that addresses patient specific situations to determine 
appropriateness of catheter selection, as well as quantifying current use can improve 
safety and quality of care for patients with VADs at this facility.  Implementing a 
standard for appropriateness of catheter selection and use has the potential to impact 
CVAD use which can lower complication rates including CLABSI and DVT resulting in 
improved outcomes for patients and lower costs for this facility.  
 Dissemination of impact of this project will occur with nurses and other 
healthcare professionals at the project site.  The impact of the proposed intervention 
could be of interest to vascular access nurses, bedside nurses, administrators, leaders, 
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educators, providers, and researchers. Project information can be disseminated through 
podium or poster presentation at the hospital during the annual presentation of quality 
improvement projects or the annual system-wide nursing conference.  After measuring 
impact and dissemination of findings, strategies for continued improvement and 
sustainability of evidence-based practices will be explored as the main goal of the quality 
improvement project is to improve care for patients. Results from this project can be 
utilized to support the implementation of proposed order sets for consultations for VAD 
placement by vascular access nurses.  This consultation service will create an opportunity 
for VAD placement to be driven by vascular access nurse teams entirely, without the 
need for provider approval or orders. Dissemination of this project to colleagues may 
increase awareness of the role of the DNP-prepared advanced practice nurse that has a 
unique skill set required to lead, develop, implement, and evaluate quality improvement 
projects in a variety of healthcare settings.   
 
Results 
Participant Demographics 
 
The evidence-based MAGIC appropriateness guideline was launched for use by 
participants within the vascular access team on December 15th, 2018.  Five out of fifteen 
(33%) of the vascular access nurses employed at the project facility participated in this 
quality improvement project.  All participants were female. Two participating nurses held 
a bachelor’s degree, two had an associate degree, and one had an associate degree in 
nursing and a bachelor’s degree in another field. All of the participants had over twenty 
years of experience as a registered nurse, two had over thirty years. All of the participants 
had over six years of experience in the vascular access specialty, one had over twenty 
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years of experience in this specialty. Four out of five participants were certified as 
Vascular Access Nurses by the Association for Vascular Access (AVA) and one 
participant held an additional certification as a Certified Registered Nurse of Infusion 
(CRNI) by the Infusion Nurses Society (INS).  
Current Evidence-Based Guideline Used 
Four out of five nurses reported using some kind of evidence-based guideline in 
current practice.  Two participants reported following the Infusion Nurse Society 
standards, one reported following the Association for Vascular Access guidelines, and 
one reported following both Infusion Nurses Society standards and the Association for 
Vascular Access guidelines.  All participants referenced using a “hospital-based 
guideline” created by a previous manager that was at least three years old and did not 
include an evidence-based citation or reference list.  Two nurses reported they were 
“somewhat familiar” with MAGIC guidelines, three reported they were “less than 
somewhat familiar” with the guidelines.  
Role in VAD Selection Pre-Survey  
When completing the Role in VAD Selection Pre-Survey (Appendix F) on 
confidence in practice, four out of five nurses reported they were “very comfortable” 
discussing vascular access device selection with providers and bedside nurses.  One nurse 
felt “less than very, more than somewhat comfortable” in this discussion and specified 
difficulty with certain medications and lack of an organization-approved medication list.  
All nurses reported feeling “very confident” in their clinical recommendations for 
vascular access device selection.  Four out of five nurses felt that providers and bedside 
nurses were “very likely” to value their recommendations regarding vascular access 
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device selection.  One nurse felt that providers and bedside nurses were “less than very, 
more than somewhat likely” to value their recommendation, specifically reporting 
concerns with specialized intensive care unit providers.  
MAGIC Criteria for VAD Selection Pre-Assessment  
When completing the MAGIC Criteria for VAD Selection Pre-Assessment 
(Appendix G) to measure knowledge of five critical content areas of the MAGIC 
evidence-based guideline, all nurses were able to correctly identify the necessary factors 
to consider when choosing the most appropriate vascular access device for a patient 
scenario.  For the second content area, all nurses were able to correctly identify the most 
appropriate lines for emergent situations, specifically addressing the inappropriateness of 
PICCs in these situations. When asked to identify the correct indication for MC 
placement, to assess the third content area, two nurses correctly chose MC for the given 
scenario. One nurse correctly chose MC, but indicated hesitation with this selection, 
specifically stating reasoning related to medications ordered in the future that may be 
inappropriate for this line, but the vascular access nurse is unable to monitor this line over 
time to intervene. One nurse incorrectly chose PICC, stating this is the safer choice as 
other medications that were inappropriate for MC could be ordered and administered in 
correctly, especially given the ICU setting addressed in the question. One nurse stated the 
question could not be answered because more information was needed, included patient’s 
specific vasculature and plan of care for this patient including future medications. For 
content question four, all nurses were able to appropriately identify indications for PICC 
use. When asked to identify appropriate removal of PICC, for the final content area, four 
out of five nurses incorrectly chose PICC to remain in place without an appropriate 
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indication. One nurse stated more information was needed, but still felt the PICC should 
remain.  One nurse correctly chose to remove the PICC when it was no longer indicated 
for the patient. 
MAGIC Criteria for VAD Selection Post-Assessment  
On the MAGIC Criteria for VAD Selection Post-Assessment (Appendix H), all 
participants were able to utilize the MAGIC reference materials to select the most 
appropriate action for each content area (Table 1).  Participants again reported that more 
patient specific information could be required when selecting the most appropriate VAD.  
On the post-assessment, all of the participating vascular access nurses reported hesitation 
for placing MCs and PIVs in certain scenarios because they felt that bedside nurses may 
not recognize the signs of infiltration as early as vascular access nurses. Participants 
reported concern that patients were at risk for these complications with inappropriate use 
of VADs placed and delayed identification and treatment of these complications.  
Table 1.  MAGIC Criteria for VAD Selection Pre and Post Assessment Results  
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MAGIC Criteria for VAD Selection Data Collection  
MAGIC Criteria for VAD Selection Data Collection (Appendix J) was collected 
by participants using the MAGIC Criteria for VAD Selection Data Collection Tool 
(Appendix I) between December 15th, 2018 and March 15th, 2019.  Forty-one device 
selection encounters were recorded.  Fourteen VAD requests (34%) made by providers 
were inappropriate for the patient situation according to the MAGIC evidence-based 
guideline (Table 2).  In all of these cases (100%), the vascular access nurse discussed a 
more appropriate VAD selection with the provider and for each encounter, the MAGIC 
evidence-based recommendation was followed.   
Table 2.  MAGIC Criteria for VAD Selection Results  
 
In ten (24%) of these inappropriate cases, a PICC was ordered by the provider and 
another VAD, specifically a MC for seven of these cases, was placed instead after the 
vascular access nurse made a recommendation (Table 3).  Six of the cases involving an 
inappropriate PICC order were related to medication duration of therapy.  Two of the 
cases involved patients who already had appropriate access given their clinical scenario 
Appropriate According to MAGIC (27) Inappropriate According to MAGIC (14)
34% 
66% 
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and did not require a PICC.  One case was inappropriately ordered in an emergency 
situation and one reasoning was not documented by the vascular access nurse.  
Out of forty-one documented VAD requests, twenty-three (56%) PICCs were 
placed by vascular access nurses during the data collection period.  Documented reasons 
for PICC requests and appropriate placement according to MAGIC evidence-based 
guidelines included orders for unspecified peripherally incompatible infusions including 
TPN (6), duration of infusion therapy (4), TPN specifically (3), chemotherapy (3), unable 
to obtain another form of access and VAD necessary for surgical intervention (1) (Table 
4).  Rationale for PICC placement was not specified in six cases.  
Table 3.  MAGIC Criteria for VAD Selection Inappropriate PICC Request Outcomes 
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Table 4.  MAGIC Criteria for VAD Selection PICC Rational Results  
 
Role in VAD Selection Post-Survey  
The Role in VAD Selection Post-Survey (Appendix K) was conducted at the end 
of the data collection period.  Four out of five participants completed the post-
intervention survey. When assessing to what extent the MAGIC evidence-based 
guidelines supported decision making, two nurses felt the guidelines were “very 
supportive”, one reported “somewhat supportive”, and one reported “less than very, more 
than somewhat supportive”.  When asked how comfortable participants felt using 
MAGIC evidence-based selection criteria to discuss vascular access device selection with 
providers/bedside nurses, one nurse felt “very comfortable”, two felt “somewhat 
Unspecified peripherally incompatible infusions (6)
Duration of infusion therapy (4)
Specified TPN (3)
Chemotherapy (3)
Unable to obtain another form of access (1)
Not Specified (6)
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comfortable”, and one felt “less than very, more than somewhat comfortable”.  When 
asked how confident nurses were in recommendations made regarding vascular access 
device selection when using the MAGIC evidence-based guidelines, one nurse felt “very 
confident”, two felt “somewhat confident”, and one felt “less than very, more than 
somewhat confident”.  When asked how likely providers/bedside nurses were to value the 
vascular access nurses’ recommendation regarding vascular access device selection when 
using the MAGIC evidence-based guidelines, one reported “very likely”, two “somewhat 
likely”, and one “less than very, more than somewhat likely”.  
When asked to provide open-ended response to explain how the MAGIC 
evidence-based selection criteria changed the vascular access nurses’ practice the 
following responses were obtained.  One participant felt the guidelines did not change 
practice and “We base our decision on what medications and what the line is for”. One 
participant felt the guidelines didn’t significantly impact practice because “we already 
follow these guidelines, practices.” This participant did feel that this guideline would be 
beneficial for use on the inpatient units by nurses and providers. One participant 
expressed, “It’s important to have documented information to base any decisions on” and 
thought the guideline was helpful but did not specifically address if there was a change in 
practice.  One participant did not provide a response to this question.  
When asked to provide open-ended response to explain any perceived 
circumstances that were not addressed by the guidelines, the following responses were 
presented. One participant felt the criteria was too vague to address the complexities of a 
given patient scenario.  One participant expressed need for guidelines to specifically 
address DVT prevention in specific situations, especially oncology, including 
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recommended length of time to wait before placing another PICC in an extremity with 
previous PICC-related DVT. This participant also felt the guidelines needed to address 
PICC placement for mastectomy patients. One participant reported no perceived 
circumstances that were not addressed by the guideline. One participant did not provide a 
response to this question.  
Discussion 
All participants began this project with a reported strong knowledge base and 
confidence in their practice specialty, including when making recommendations to 
providers and bedside nurses.  All participants had many years of experience in nursing 
and in the vascular access specialty, specifically, four of the participants were certified in 
the specialty. This could have impacted their readiness and willingness to utilize a new 
evidence-based guideline, presented from someone outside of their department, that may 
contradict some of their current practices.    
The pre-test demonstrated that vascular access nurses were knowledgeable in 
three of the key content areas addressed by the evidence-based MAGIC guidelines.  The 
question assessing knowledge of appropriate indication for MC placement created an 
opportunity for impact in knowledge base as three nurses were unable to correctly 
address this content area.  As participants gained knowledge regarding indications for 
MC placement, potential value specific to increase use of MCs in place of CVADs can 
positively impact patient outcomes through prevention of risk associated with 
inappropriate CVAD use.  
 For the question addressing PICC indications specifically, four nurses incorrectly 
identified indications for PICC removal and opted for PICC to remain in place when no 
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longer indicated.  This created an opportunity for impact on knowledge base regarding 
appropriate indication for removal of PICC line for most participants. This increase in 
knowledge base for participants added potential value to project outcomes through 
decreased device utilization days and complications rates, as each day that a PICC 
remains in place without indication places patients at unnecessary risk for adverse 
outcomes (Chopra et al., 2012).   
During the education session, all participants demonstrated ability to utilize the 
MAGIC reference materials to select the most appropriate action for each content area.  
The MAGIC evidence-based guidelines impacted the participant’s knowledge base and 
can be used as reference by participants when making VAD recommendations. Per data 
collected through the MAGIC Criteria for VAD Selection Data Collection Tool 
(Appendix I), results indicate that providers and bedside nurses may not be adequately 
informed, or lack the resources necessary, to select the most appropriate VAD for a 
patient scenario, according to MAGIC evidence-based guidelines.  Vascular access 
nurses demonstrated an impact on VAD selection as all inappropriate requests by 
providers or bedside nurses prompted an interprofessional discussion between vascular 
access nurse and provider or bedside nurse, which result in following the MAGIC 
evidence-based recommendation.  
It can be argued that some of these discussions and recommendations may have 
been made by vascular access nurses, regardless of the implementation of MAGIC 
evidence-based guidelines, given their baseline knowledge of this subject area.  It should 
be noted that seven inappropriate PICC requests resulted in placement of MCs by 
vascular access nurses. In comparison of pre and post-tests, three nurses gained 
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knowledge specifically related to MC indications and may not have appropriately 
recommended a MC for these patients without the MAGIC evidence-based guideline.  
This suggests that the MAGIC evidence-based guideline may be an effective tool for use 
by vascular access nurses to improve appropriateness of VAD selection in this acute care 
setting.  These findings suggest equipping the vascular access nurses with the MAGIC 
evidence-based guidelines and knowledge may have prevented at least seven 
inappropriate PICC placements and, thus, is a valuable contribution to practice.  
On post-survey, nurses felt the MAGIC evidence-based guidelines adequately 
supported clinical decision making. Participants felt comfortable and confident using the 
guideline, but this perceived comfort was, overall, less comfortable and confident than 
the reported comfort and confidence in making recommendations before guidelines were 
introduced.  Vascular access nurses reported providers and nurses to be “more than 
somewhat likely” to value their recommendation when using the guideline, but this result 
is less likely than their perceived value before guidelines were introduced.  Given the 
post-test demonstrating participants are able to use the guideline appropriately, this 
reduced confidence may indicate that the facility culture may not support participants to 
use this guideline appropriately.  
Open-ended responses revealed that overall, nurses felt that evidence was 
important to guide practice, but did not feel that the guideline could adequately address 
specific issues pertaining to their institution and various populations and, therefore, could 
not be followed in all circumstances.  Throughout the project, participants reported that 
the MAGIC evidence-based guidelines could not adequately address all of the 
characteristics involved in specific patient scenarios. The need for an individualized 
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approach in certain situations, particularly when attempting to estimate duration, is 
acknowledged in the MAGIC guidelines (Chopra et al., 2015).  
 Vascular access nurses reporting feeling hesitant to follow MAGIC evidence-
based guidelines, specifically recommendations for MC placement, as they did not feel 
providers and bedside nurses were knowledgeable of appropriate use of VADs.  At the 
project facility, the vascular access team nurses are unable to routinely monitor VADs 
after placement due to volume of VADs placed and limited number of vascular access 
nurses.  Specifically, the participants are concerned that a VAD will be initially placed 
appropriately for a patient, but as the plan of care changes for that patient, the vascular 
access team is not prompted to reevaluate the appropriateness of the line.  This leaves 
providers and bedside nurses to evaluate appropriateness on an ongoing basis without 
specialty consult from a vascular access nurse.  The participants felt VADs may be used 
inappropriately in these situations and could result in patient harm.  Vascular access 
nurses also expressed that bedside nurses and providers may have delayed insight into 
early signs of complications associated with inappropriate VAD use.  Given the 
anatomical positioning of MCs, vascular access nurses fear patient harm resulting from 
an infiltration that may have been caught earlier with routine monitoring by the vascular 
access team. 
In discussion of application, the MAGIC guideline authors acknowledge that 
appropriateness of VAD selection may be influenced by the health care setting (Chopra et 
al., 2015).  The authors note that in particular facilities in which expertise and clinical 
support are limited, reliability of the VAD may be more important than appropriateness 
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for certain situations.  This caveat parallels variances in practice between inpatient 
nursing units and the vascular access team at the project facility.   
Given these concerns, vascular access nurses are more likely to place a PICC 
against recommendations if they suspect the plan of care will change for the patient and 
an MC will be used appropriately in the future.  Vascular access nurses acknowledge a 
desire to routinely monitor all VADs placed, specifically MCs, as this would provide 
reassurance when placing a VAD according to recommendations. Vascular access nurses 
reported some personal accountability to patient harm resulting from VADs placed and 
felt a negative outcome associated with a VAD placed could reflect poorly on their 
practice. The participants may have perceived the risk of CLABSI associated with 
unnecessary PICC placement to be less severe than the potential risk of inappropriate use 
of a MC.  The participants may have measured the personal accountability of a negative 
outcome of a VAD placed as an increased perceived risk.  These challenges present 
significant barriers to sustained adoption of this practice guideline for use in the project 
facility.  
Successful adoption of an evidence-based guidelines requires, ideally, that 
participants are practicing within a healthy work environment. The American Association 
of Critical Care Nurses (2016) maintains that six essential standards including, skilled 
communication, true collaboration, effective decision making, appropriate staffing, 
meaningful recognition, and authentic leadership must be in place to ensure a healthy 
work environment exists that will support patient safety and high-quality care.   Feedback 
from participating vascular access nurses suggests the project facility may not fully 
uphold all standards required for practice in a health work environment.  Participants 
61 
 
reported lack of education of team members to develop and master skilled 
communication to support interprofessional collaboration necessary to impact patient 
care.  Interprofessional collaboration is best supported by health care organizations that 
evaluate team member accountability and address unwillingness to collaborate 
appropriately, with an emphasis on incorporating the decision-making authority of nurses 
(AACN, 2016). 
Interestingly, data collection and reports from participants demonstrated a shared 
common goal among interdisciplinary team members, but differing opinions on how to 
achieve the goal.  Vascular access nurses, providers, and bedside nurses all shared the 
common goal of reduced harm associated with vascular access devices, but not all 
members understood the weight and associated risk of each potential complication.  
Professionals from different disciplines had varying priorities in harm reduction practices 
and often disagreed about course of action. Without the support of a healthy work 
environment, vascular access nurses will be unable to utilize the decision support tools to 
sustain participation in true collaboration and effective decision-making in the health care 
team. 
The participating nurses reported a lack of formal leadership assigned to the 
vascular access team for over two years.  Without authentic leadership, the team lacked 
support, mentoring, enthusiasm, and performance review necessary to support advancing 
practice (AACN, 2016).  Lack of leadership and any form of meaningful recognition 
created insurmountable barriers to sustaining utilization of MAGIC guidelines to support 
vascular access nurse recommendations including role dissatisfaction and decreased 
willingness to participate, resulting in a 33% participation rate for this project. 
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 An optimal environment designed to support the autonomous practice of nurses is 
ideal when implementing a new evidence-based guideline that may change practice.   
According to Krein et al. (2017), hospitals with vascular access nurses who perceive their 
role in VAD decision-making to be valued by other members of the healthcare team have 
a lower frequency of inappropriate PICC use. Vascular access nurses who felt they were 
valued consultants had more experience in practice and placing PICCs than the other two 
role groups (Krein et al., 2017). Findings from these researchers indicate that 
understanding how to promote interprofessional collaboration is critical to ensuring 
improved appropriateness of PICC use in hospitals with vascular access teams (Krein et 
al., 2017). Further research is needed to better understand the association between the 
perceived role of the vascular access nurse and device utilization practices.   
Conclusion 
 
The MAGIC evidence-based guideline positively impacted the knowledge base of 
vascular access nurses regarding appropriate indication for MC use and removal of PICC 
for most participants. This increase in knowledge base for participants added potential 
value to improve appropriateness of VAD use and reduce risk of associated 
complications.  Providers and bedside nurses may not be adequately informed, or lack the 
resources necessary, to select the most appropriate VAD, according to MAGIC evidence-
based guidelines, given a patient scenario.  Vascular access nurses’ impact VAD 
selection and reduce patient exposure to unnecessary risk associated with PICCs through 
interprofessional discussion with the care team and evidence-based recommendation.   
The MAGIC evidence-based guideline may be an effective tool for use by 
vascular access nurses to improve appropriateness of VAD selection in this acute care 
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setting.  Equipping the vascular access nurses with the MAGIC evidence-based 
guidelines and knowledge may have prevented at least seven inappropriate PICC 
placements and, thus, is a valuable contribution to practice. Project facility culture may 
not support vascular access nurses to sustain use of the MAGIC guideline.  Vascular 
access nurses acknowledge that evidence is important to guide practice, but do not feel 
that the guideline can adequately address specific issues pertaining to their institution and 
patient population and therefore could not always be followed.  Successful adoption and 
sustained utilization of the MAGIC guideline within a facility requires an established 
healthy work environment that supports clinicians with access to evidence-based tools 
and knowledge necessary to support interprofessional collaboration around clinical 
decision making in VAD selection.   
Recommendations 
To achieve sustained appropriate use of the MAGIC guideline throughout the 
facility, this guideline must be implemented for use across disciplines and beyond the 
vascular access nurses.  Expert recommendation from vascular access nurses is key to 
decision-making, but due to limited number of VAD specialty nurses available to place 
and monitor VAD use, sustained best practice in this area requires that all clinicians are 
able to access and utilize MAGIC decision criteria for optimal interprofessional 
collaboration and practice.  Successful implementation and sustained appropriate 
utilization of the MAGIC guideline requires innovative leadership within an established 
healthy work environment.  
The MAGIC guideline authors acknowledge important limitations to this 
appropriateness criteria including a limited understanding to how to best implement these 
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recommendations into practice.  Chopra et al. (2015) emphasize the importance of 
implementing and utilizing the MAGIC guideline not as a final, conclusive document, but 
rather a guide that is everchanging and revised as new evidence emerges and updated 
practice recommendations are made available.  Given the potential of CDS system 
technology to provide the user with continuously updated information at the point of care, 
this format is likely the most appropriate tool to accomplish the goals of MAGIC 
guideline implementation.  With a clinical decision support tool in place, vascular access 
nurses will be empowered to drive change through new workflow processes that enhance 
quality of care.  CDS tools have the ability to support healthcare clinicians at the point of 
care by providing evidence-based standardization support while allowing consideration to 
the individual needs of a patient (TIGER Initiative Foundation, 2014).  Clinical decision 
support tools that utilize patient data and the latest evidence-based practice 
recommendations to create alerts and prompt action by providers could be incorporated 
into data collection tools of all kinds that are currently in place to prevent increased risk 
and missed care. 
For this particular guideline, the CDS tool would ensure information is 
continuously updated for use beyond the vascular access nurses to clinicians from all 
disciplines throughout the facility.  The CDS system provides the ability to incorporate 
pertinent patient-specific information to guide the clinician to the most appropriate device 
for the individual.  Ideally, the CDS tool could alleviate some concerns of vascular access 
nurses by incorporating an alert warning for inappropriate use of VADs after placement. 
The success of a CDS tool implementation is largely dependent on planning, 
support during implementation, and post implementation evaluation and optimization that 
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can only occur successfully in a healthy work environment.  Nursing involvement in 
technology the CDS program design, implementation, and evaluation is essential to the 
success of the program (American Nurses Association, 2014).  This evaluation process is 
crucial to completing the transition and sustaining the changes associated with CDS 
implementation.  Usability surveys for end-users can be used to determine certain criteria 
be tailored to specific unit needs, these items could have been incorporated to meet the 
needs of the user and improve satisfaction with the tool. 
Implementing a CDS with a user-centered design would be ideal to supporting 
optimal usability of the product.  An iterative design involves having users evaluate a 
CDS tool’s usability to determine effectiveness and efficiency in decision making and 
care processes and using feedback to make improvements (Nelson & Staggers, 2018).  
Designers have users interact with the tool to determine barriers and areas for 
improvement before implementation.  Users are then encouraged to provide feedback to 
informatics leadership after using the system for several months.  A user-centered design 
would include a focus on a deep understanding of the end-users including their practice 
environment, characteristics, and daily tasks (Nelson & Staggers, 2018).  This 
understanding requires frequent contact with users throughout the design process to 
ensure the CDS tool will meet their needs.  Given the large size of the project facility, 
champion users could be utilized to represent each specialty, discipline, and practice area 
to ensure a manageable process of implantation through peer support.  Champions can be 
selected from each area to receive additional training and practice and provide peer-to-
peer assistance to enhance adoption and use.    
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According to the TIGER Initiative Foundation (2014), the innovative nurse leader 
should possess the skills needed to effectively design and implement this clinical tool 
with input from key stakeholders.  Future testing of the effectiveness and efficiency of a 
CDS tool like this will prompt leadership to make critical changes and improvements that 
will support the success and sustainability of the new technology.  The innovative nurse 
leader employs professional interoperability, strong professional skills utilized to share 
knowledge, expertise, and meaningful information across disciplines (TIGER Initiative 
Foundation, 2014).  More research and evaluation pertaining to the role of the vascular 
access nurse in VAD decision-making and the use of CDS systems in this specialty are 
needed. 
Implications for Practice 
 
 Doctor of Nursing Practice prepared professionals are essential to leading and 
collaborating within a health care team to evaluate access to care, health care costs, 
quality indicators and patient outcomes, and established evidence-based standards 
(Hickey & Brosnan, 2016). Understanding nursing practice, how nurses’ function as a 
member of the interdisciplinary team, and strategies to maximize the autonomy of 
practice to positively impact safety of care delivered and support sustained high-quality 
care is essential to future practice.  Moving forward, health care organizations must 
function to support the delivery of safe, effective, patient-centered health care in a timely 
and efficient manner (Hickey & Brosnan, 2016).  To do this, organizations must foster 
growth of health care professionals to practice to evidence-based standards, provide 
patient-centered care, and engage in interprofessional collaboration.  Incorporating 
innovative CDS tools to support evidence-based practice within a healthy work 
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environment that fosters true interprofessional collaboration is essential to high-quality 
care and a sustainable health care system.  
  
 
 
  
68 
 
References 
Adams, D. Z., Little, A., Vinsant, C., & Khandelwal, S. (2016).  The midline catheter: A 
clinical review.  The Journal of Emergency Medicine, 51(3), 252-258.  
Al Raiy, B., Fakih, M.G., Bryan-Nomides, N., Hopfner, D., Riegel, E., Nenninger, T….  
Khatib, R. (2010).  Peripherally inserted central venous catheters in the acute care  
setting: A safe alternative to high-risk short-term central venous catheters.  
American Journal of Infection Control, 38(2), 149-53. 
American Nurses Association.  (2014).  Standardization and interoperability of health 
information technology: Supporting nursing and the national quality strategy for 
better patient outcomes.  Retrieved from: 
http://www.nursingworld.org/positionstatements.  
American Association of Critical Care Nurses (AACN).  (2016). AACN Standards for  
establishing and sustaining healthy work environments.  Aliso Viejo, CA: AACN. 
Berner, E.S. (2009).  Clinical decision support systems: State of the art. Agency for  
Healthcare Research and Quality.  Retrieved from: 
https://healthit.ahrq.gov/sites/default/files/docs/page/09-0069-EF_1.pdf 
Caparas, J.V. & Hung, H.S. (2017). Vancomycin administration through a novel midline 
 catheter: Summary of a 5-year, 1086- patient experience in an urban community 
 hospital. The Journal of the Association for Vascular Access, 22(1), 38-41. 
Centers for Disease Control and Prevention (CDC).  (2011a).  Guidelines for the  
Prevention of Intravascular Catheter-Related Infections.  Retrieved from 
https://www.cdc.gov/infectioncontrol/guidelines/BSI/index.html  
69 
 
Centers for Disease Control and Prevention (CDC).  (2011b).  CDC’s Healthcare 
Infection Control Practices Advisory Committee (CDC/HICPAC) Guidelines for 
the Prevention of Intravascular Catheter-Related Infections.  Retrieved from:  
https://www.cdc.gov/hai/pdfs/bsi-guidelines-2011.pdf 
Centers for Disease Control and Prevention (CDC).  (2018).  National and State  
Healthcare-Associated Infections Progress Report.  Retrieved from:  
https://www.cdc.gov/hai/data/portal/progress-report.html 
Centers for Disease Control and Prevention (CDC).  (2019).  Bloodstream infection event  
(central line-associated bloodstream infection and non-central line associated  
bloodstream infection).  Retrieved from: 
https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf.  
Chopra, V., Kuhn, L., Coffey, C.E., Salameh, M., Barron, J., Krein, S.,… Saint, S. 
(2013).  Hospitalist experiences, practice, opinions, and knowledge regarding  
peripherally inserted central catheters: A Michigan survey.  Journal of Hospital  
Medicine, 8(6), 309-314.  
Chopra, V., Flanders, S.A., & Saint, S. (2012). The problem with peripherally inserted  
central catheters.  Journal of the American Medical Association, 308(15):1527-
1528. 
Chopra, V., Flanders, S.A., Saint, S., Woller, S.C., O’Grady, N.P., Safdar, N.,…  
Bernstein, S.J. (2015).  The Michigan appropriateness guide for intravenous  
catheters (MAGIC): Results from a multispecialty panel using the RAND/UCLA  
appropriateness method.  Annals of Internal Medicine, 163(6). 
Chopra, V., Kuhn, L., Ratz, D., Flanders, S.A., & Krein, S.L. (2016). Vascular nursing  
70 
 
experience, practice knowledge, and beliefs: Results from the Michigan PICC1  
survey. Journal of Hospital Medicine, 11(4), 269-275.   
Chopra, V., Kuhn, L., Ratz, D., Shader, S., Vaughn, V.M., Saint, S., & Krein, S.L. 
 (2017).  Vascular access specialist training, experience and practice in the United 
States: results from the national PICC1 survey.  Journal of Infusion Nursing, 
40(1), 15-25. 
Cortez, S., Dietrich, M.S., & Wells, N. (2016).  Measuring clinical decision support  
influence on evidence-based nursing practice.  Oncology Nursing Forum, 43(4)  
E170-E177.  
Curley, M.A.Q. (2007). Synergy: The unique relationship between nurses and patients. 
 Indianapolis, IN: Sigma Theta Tau International. 
Fitch, K., Bernstein, S.J., Aguilar, M.D., Burnand, B., LaCalle, J.R., Lazaro, P., … Kahan,  
J.P. (2001).  The RAND/UCLA appropriateness method user’s manual. Retrieved  
from: https://www.rand.org/pubs/monograph_reports/MR1269.html  
Gunst, M., Matsushima, K., Vanek, S., Gunst, R., Shafi, S., Frankel, H. (2011).  
Peripherally inserted central catheters may lower the incidence of catheter-related  
blood stream infections in patients in surgical intensive care units.  Surg Infect  
(Larchmt) 12(4), 279-82.  
Hardin, S. (2013).  The AACN synergy model. In Peterson, S. J. & Bredow, T.S. (Eds.),  
Middle range theories: Application to nursing research (pp. 294-305) (3rd ed.).  
Philadelphia, PA: Wolters Kluwer.  
 Hickey, J. V., & Brosnan, C. A. (Eds.).  (2016). Evaluation of Health Care Quality for  
DNPs (2nded.).  New York, NY.  Springer Publishing Company. 
71 
 
Idemoto, B.K., Rowbottom, J.R., Reynolds, J.D., & Hickman, R.L. (2014).  The  
AccuCath intravenous catheter system with retractable coiled tip guidewire and  
conventional peripheral intravenous catheters: A prospective, randomized,  
controlled comparison. Association for Vascular Access, 19(2), 94-102.  
Krein, S.L., Kuhn, L., Ratz, D., Winter, S., Vaughn, V.M., & Chopra, V. (2017). The  
 relationship between perceived role and appropriate use of peripherally inserted  
central catheters: A survey of vascular access nurses in the United States.  
International Journal of Nursing Studies, 71, 28-33.  
Lewin, K. (1951).  Field theory in social science.  New York: Harper and Brothers.  
McEwen, M., & Wills, E. M. (2011).  Theoretical basis for nursing.  Philadelphia  
Wolters Kluwer Health/Lippincott Williams & Wilkins.  
Meyer, B.M. (2012).  Developing an alternative workflow model for peripherally inserted  
 central catheter placement.  Journal of Infusion Nursing, 35(1). 
Moureau, N., Sigl, G., & Hill, M. (2015). How to establish an effective Midline Program:  
A case study of 2 hospitals.  Association for Vascular Access, 20(3), 179-188.  
Nelson, R. & Staggers, N. (2018).  Health Informatics: An interprofessional approach.  
(2nd Ed.).  St. Louis, MO: Elsevier Mosby.  
Pathak, R., Patel, A., Enuh, H., Adekunle, O., Shrisgantharajah, V., & Diaz, K. (2015).  
The incidence of central line-associated bacteremia after the introduction of  
midline catheters in a ventilator unit population.  Infectious Disease in Clinical  
Practice 23, 131-134. 
72 
 
Smith, A. R. (2013). The AACN synergy model. In Peterson, S. J. & Bredow, T.S. (Eds.), 
 Middle range theories: Application to nursing research (pp. 331-333) (3rd ed.). 
 Philadelphia, PA: Wolters Kluwer.  
Stewart, M. W. (2018). Models and theories focused on competencies and skills. In Butts,  
J. B. & Rich, K. L. (Eds.), Philosophies and theories for advanced nursing  
practice (pp. 519-543).  Burlington, M: Jones & Barlett Learning.  
Swaminathan, L., Flanders, S., Rogers, M., Calleja, Y., Snyder, A., Thyagarajan, R.,… 
& Chopra, V. (2018). Improving PICC use and outcomes in hospitalized patients: 
an interrupted time series study using MAGIC criteria. BMJ Qual Saf, 27(4), 271-
278.  
TIGER Initiative Foundation.  (2014).  The Leadership Imperative: TIGER’s  
recommendations for integrating technology to transform practice and education.  
Retrieved from: https://www.himss.org/professionaldevelopment/tiger-initiative 
Xu, T., Kingsley, L., DiNucci, S., Messer, G., Jeong, J.H., Morgan, B.,… & Yassin, 
M.H. (2016).  Safety and utilization of peripherally inserted central catheters 
versus midline catheters at a large academic medical center.  American Journal of 
Infection Control, 44(1), 1458-61. 
 
  
73 
 
Appendix A 
The Michigan Appropriateness Guide for Intravenous Catheters (Chopra et al., 2015) 
Venous access device recommendations for infusion of peripherally compatible infusates. 
 
 
Figure Legend: IV = intravenous; PICC = peripherally inserted central catheter; US = 
ultrasonography.  
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Appendix B 
The Michigan Appropriateness Guide for Intravenous Catheters (Chopra et al., 2015) 
Venous access device recommendations for infusion of non–peripherally compatible 
infusates. 
 
Figure Legend: IV = intravenous; PICC = peripherally inserted central catheter; US = 
ultrasonography.  
 
  
75 
 
Appendix C 
The Michigan Appropriateness Guide for Intravenous Catheters (Chopra et al., 2015) 
Venous access device recommendations for patients with difficult venous access. 
 
Figure Legend: 
IV = intravenous; PICC = peripherally inserted central catheter; US = ultrasonography.  
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Appendix D 
The Michigan Appropriateness Guide for Intravenous Catheters (Chopra et al., 2015) 
Venous access device recommendations for patients who require frequent phlebotomy. 
 
Figure Legend: IV = intravenous; PICC = peripherally inserted central catheter; US = 
ultrasonography.  
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Appendix E 
 
VAD Selection Education Session Outline 
 
Location: Project facility vascular access breakroom.  
 
1. Project Introduction- overview of project goals, invitation to participate, 
participants agree to participate.  
 
2. Participants complete Role in VAD Selection Pre-Survey 
 
3. Participants complete MAGIC Criteria for VAD Selection Pre-Assessment 
 
4. Introduction to MAGIC research and summary of recommendations for practice 
 
5. Introduction to MAGIC guidelines and discussion of use.  
 
6. Participants complete MAGIC Criteria for VAD Selection Post-Assessment 
 
7. Introduction to data collection tool and instructions for use.  
 
8. Questions addressed, contact information provided for project concerns.  
 
9. Reminder to complete VAD Selection Post-Survey at conclusion of project.  
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Appendix F 
 
Role in VAD Selection Pre-Survey 
Demographics:  
 
1. Sex:    Male    Female    Prefer not to respond  
 
2. What is your highest degree completed?     Diploma    Associates     Bachelors     Masters    
 
3. How many years have you practiced as a Registered Nurse?  
 
5 years or less         6-10     11-15  16-20   21-25   26-30   30+ 
 
4. How many years have you practiced as a vascular access nurse?  
 
5 years or less         6-10     11-15  16-20   21-25   26-30   30+ 
 
5. Do you hold a certification in a vascular access specialty?         Yes         No      
If yes, please specify:  
 
Perceived Comfort in Role Questions  
 
1. Do you currently follow an evidence-based guideline for vascular access device 
selection?  Yes    No              If yes, please specify: 
 
2. How familiar are you with Michigan Appropriateness Guide for Intravenous Catheters 
(MAGIC)?  
 
Not familiar at all-1               2       Somewhat familiar-3           4        Very familiar -5 
 
3. How comfortable are you with discussing vascular access device selection with 
providers/bedside RNs?  
 
Not comfortable at all-1         2     Somewhat comfortable-3       4         Very comfortable-5 
 
 
4. How confident are you in your recommendations regarding vascular access device 
selection?  
 
Not confident at all-1              2     Somewhat confident-3          4         Very confident-5 
 
 
5. How likely are providers/bedside RNs to value your recommendation regarding vascular 
access device selection?  
 
Not likely at all-1                  2         Somewhat likely-3                4         Very likely-5 
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Appendix G 
 
MAGIC Criteria for VAD Selection Pre-Assessment 
 
Indicate the most appropriate answer given the scenario provided.  
 
1. Many factors are considered when choosing the most appropriate vascular access 
device for a patient including:  
a. Duration of use, provider preference, time of day vascular access device is 
placed  
b. Nurse preference, infusates ordered, availability of equipment  
c. Indication, anticipated duration of use, infusates ordered/anticipated 
 
2. A critically ill patient in the emergency room needs central access for 
resuscitation and vasoactive medications.  The emergency room nurse pages the 
vascular access nurse for an urgent PICC placement.  What is the most 
appropriate action? 
a. Place the PICC as quickly as possible 
b. Call the emergency room nurse to tell him that you will not place the 
PICC until the patient is moved to the ICU  
c. Discuss the most appropriate evidence-based options for vascular 
access with consideration to patient-specific needs with the provider 
and/or primary nurse including large-bore peripheral IV, introducer 
sheath, or centrally inserted central catheter  
 
3. The provider pages the vascular access nurse for assistance with access for an 
ICU patient.  Upon review of the patients’ chart the vascular access nurse finds 
that the patient has a history of difficult access with multiple peripheral catheter 
attempts, the ordered infusates are peripherally compatible, and the proposed 
duration of therapy is approximately 10 days.  What is the most appropriate 
action? 
a. Place a midline and provide education to the primary nurse and 
patient as needed 
b. Educate and obtain consent from the patient to place a PICC  
c. Collaborate with pharmacy and the provider to convert all medications to 
PO  
 
4. The plan of care for a post-op patient includes TPN for at least 20 days. The 
provider places an order for a PICC. What is the most appropriate action?  
a. Recommend the provider place centrally inserted central line as duration 
of use is only 20 days.  
b. Recommend a midline to prevent CLABSI and report the inappropriate 
PICC order to the infection control department.  
c. Place a PICC after review of the chart and/or discussion with primary 
nurse or provider to confirm patient does not have any 
contraindications for PICC placement.   
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5. A patient with a PICC no longer has non-peripherally compatible infusions 
ordered, has an anticipated discharge in 3 days, and PICC has not been used for 
an evidence-based clinical indication in 48 hours.  Discussion with the primary 
nurse reveals that the PICC remains in place for morning labs for patient comfort. 
What is the most appropriate action by the vascular access nurse? 
a. No action required, this PICC can remain for the 3 days until discharge. 
Be sure to remove PICC before patient leaves the hospital. 
b. Notify provider of evidence-based reason to remove PICC, confirm 
plan to remove PICC, remove PICC and assist with appropriate 
vascular access device placement for this patient if needed.  
c. Ask the primary nurse to remove the PICC when she has time. 
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Appendix H 
 
MAGIC Criteria for VAD Selection Post-Assessment 
 
Indicate the most appropriate answer given the scenario provided.  
 
1. According to MAGIC evidence-based guidelines, many factors are considered 
when choosing the most appropriate vascular access device for a patient 
including:  
a. Provider preference, duration of use, time of day vascular access device is 
placed  
b. Indication, anticipated duration of use, infusates ordered/anticipated 
c. Infusates ordered, availability of equipment, primary nurse preference  
 
2. A provider places a STAT request for PICC placement by the vascular access 
team for a hemodynamically unstable ICU patient.  According to the MAGIC 
evidence-based guidelines, what is the most appropriate action? 
a. Place the PICC as quickly as possible 
b. Refuse to place the PICC and leave the unit  
c. Discuss evidence-based options for vascular access devices with 
consideration to patient-specific needs with the provider and/or 
primary nurse including large-bore peripheral IV, introducer sheath, 
or centrally inserted central catheter   
 
3. The primary nurses request a midline for a patient.  The vascular access nurse 
arrives to the unit to review the chart and discusses the plan of care with the 
primary nurse. The vascular access nurse finds that the ordered infusates are 
peripherally compatible, the patient has a history of difficult access with multiple 
peripheral catheter attempts, and the proposed duration of therapy is 
approximately 10 days.  According to the MAGIC evidence-based guidelines, 
what is the most appropriate action? 
a. Place a midline and provide education to the primary nurse and 
patient as needed 
b. Recommend a PICC 
c. Ask pharmacy to convert all medications to PO  
 
4. The vascular access nurse receives a request to place a PICC for a patient 
requiring TPN for at least 20 days. According to the MAGIC evidence-based 
guidelines, what is the most appropriate action?  
a. Recommend a midline to prevent CLABSI. 
b. Place a PICC after review of the chart and/or discussion with primary 
nurse or provider to confirm patient does not have any 
contraindications for PICC placement.   
c. Recommend provider place centrally inserted central catheter as duration 
of use is only 20 days.  
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5. A patient with a PICC no longer has non-peripherally compatible infusions 
ordered, has an anticipated discharge in 3 days, and PICC has not been used for 
an evidence-based clinical indication in 48 hours.  Discussion with the primary 
nurse reveals that the PICC remains in place for morning labs for patient comfort.  
According to the MAGIC evidence-based guidelines, what is the most appropriate 
action by the vascular access nurse? 
a. No action required, this PICC can remain for the 3 days until discharge.  
b. Ask the primary nurse to remove the PICC  
c. Notify provider of evidence-based reason to remove PICC, confirm 
plan to remove PICC, remove PICC and assist with appropriate 
vascular access device placement for this patient if needed.  
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Appendix I 
 
MAGIC Criteria for VAD Selection Data Collection Tool 
 
Vascular Access Device (VAD) Data Collection              Date____________       Unit _____________ 
 
 
1. VAD ordered/requested:      PICC          Midline       Peripheral IV         Other _____________ 
 
2. VAD placed:                          PICC          Midline             Peripheral IV        Other _____________ 
 
3. VAD requested appropriate according to MAGIC criteria?   YES      NO  
 
 If YES:   PICC placed, rational: 
 
              Midline placed, rational:  
                
              Other action taken: _____________________________ 
  
If NO, what action was taken? 
 
____  Discussion with provider/RN and MAGIC criteria followed.  
 
____ Discussion with provider/RN and VAD requested placed against MAGIC criteria.  
 
____ Other (please briefly explain):  
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 Appendix J  
 
MAGIC Criteria for VAD Selection Data Collection Results  
 
Date Unit  Ordered Placed App?  Reason 
12/15/18 BB 6 PIV PICC No UTO access, OR tomorrow 
12/16/18 6A PICC  ML No Needed for 5 days IV abx.  
12/16/18 9A PICC  PICC Yes HLOC, need meds & gtts 
12/16/18 10B  PIV ML No Unable to obtain PIV access 
12/17/18 MICU ML ML Yes CT scan IV contrast  
12/18/18 RICU PICC  none  No multiple PIVs, did not require PICC 
12/19/18 9A ML PIV No  
12/19/18 CCC3 PICC  PICC Yes  
12/21/18 SICU ML ML Yes Insulin gtt 
12/21/18 6A PICC  ML No Meds ML compatible, 2 weeks duration 
12/24/18 RICU PICC  PICC Yes incompatible meds, TPN 
12/25/18 JB 2N ML ML Yes  UTO access for blood admin 
12/27/18 RICU PICC  PICC Yes Chemo 
12/27/18 8A ML ML Yes Unable to obtain PIV access for IV fluid 
12/28/18 MICU PICC  CICC  No STAT request 
12/28/18 7B PICC  PICC Yes   
12/29/18 5ISC  PICC  PICC Yes TPN 
12/29/18 BB 6 PICC  PICC Yes  
12/29/18 JB 1N PICC  PICC Yes IV abx 6 weeks  
12/30/18 6B PICC  PICC Yes UTO access, need for gtts  
12/30/18 RICU PICC  PICC Yes UTO access, incompatible meds  
12/31/18 CCC2 PICC  ML No Duration of medication ordered 
1/12/19 5ISC  PICC  PICC Yes D/C CICC, required duration 
1/12/19 RICU PICC  PICC Yes  
1/12/19 6A ML PICC No  
1/21/19 8B PICC  PICC Yes Iv abx 6 weeks  
1/21/19 RICU PICC  PICC Yes  
1/21/19 RICU PICC  PICC Yes Multiple access needed for gtts  
1/29/19 5ISC  PICC  PICC Yes  TPN  
1/29/19 ER PICC  ML No  
2/3/19 NCCU PICC  ML No PICC not appropriate for med & duration  
2/6/19 5ISC  PICC  PICC Yes TPN  
2/6/19 8B PICC  PICC Yes Chemo 
2/6/19 8A PICC  PICC Yes Chemo 
2/6/19 RICU PICC  None  No Patient no longer needed access 
2/7/19 6B ML ML Yes IV abx and duration appropriate for ML 
2/7/19 RICU PICC  PICC Yes Multiple gtts and IV abx, UTO access  
2/7/19 6B PICC  ML No IV abx and duration appropriate for ML 
2/13/19 6A PICC  ML No Inappropriate for meds and duration  
2/17/19 MICU PICC  PICC Yes Meds ordered required PICC 
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Appendix K 
 
Role in VAD Selection Post-Survey 
 
1. To what extent did the MAGIC evidence-based guidelines support your decision making 
when selecting the most appropriate vascular access device for a patient?  
 
Did not support at all-1         2            Somewhat supported-3        4      Very supported-5 
 
2. How comfortable are you with using the MAGIC evidence-based selection criteria to 
discuss vascular access device selection with providers/bedside RNs?  
 
Not comfortable at all-1         2     Somewhat comfortable-3        4     Very comfortable-5 
 
3. How confident are you in your recommendations regarding vascular access device 
selection when using the MAGIC evidence-based guidelines?  
 
Not confident at all-1              2     Somewhat confident-3         4         Very confident-5 
 
4. How likely are providers/bedside RNs to value your recommendation regarding vascular 
access device selection when using the MAGIC evidence-based guidelines?  
 
Not likely at all-1                  2             Somewhat likely-3             4         Very likely-5 
 
5. How has the MAGIC evidence-based selection criteria change your practice?  (open-
ended) 
 
 
 
 
6. Are there any other circumstances not addressed by the guidelines that you can share? 
(open-ended)  
 
 
 
